HPTN Publications

Abdool Karim Q, Sibeko S, Baxter C . Preventing HIV infection in women: a global health imperative. Clin Infect Dis. 2010, 50: S122-9 PMCID: 3021824
Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L; HIV Prevention Trials Network (HPTN) 035 Study Team . Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011, 25: 957-99 PMCID: 3063640
Aboud S, Msamanga G, Read JS, Mwatha A, Chen YQ, Potter D, Valentine M, Sharma U, Hoffman I, Taha TE, Goldenberg RL, and Fawzi WW . Genital Tract Infection Among HIV-infected Pregnant Women in Malawi, Tanzania and Zambia. Int J STD AIDS. 2008, 19: 824-32 PMCID:2698963
Aboud S, Msamanga G, Read JS, Wang L, Mfalila C, Sharma U, Martinson F, Taha TE, Goldenberg RL, Fawzi WW . Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia. Int J Gynecol Obstet. 2009, 107: 202-07 PMCID: 2783250
Adimora AA, Hughes JP, Wang J, Haley DF, Golin CE, Magnus M, Rompalo A, Justman J, Del Rio C, El-Sadr W, Mannheimer S, Soto-Torres L, Hodder SL; for the HPTN 064 Protocol Team . Characteristics of Multiple and Concurrent Partnerships among
Women at High Risk for HIV Infection
. J Acquir Immune Defic Syndr. 2014, 65: 99-106
Adimora AA, Ramirez C, Auerbach JD, Aral SO, Hodder S, Wingood G, El-Sadr W, Bukusi EA; HIV Prevention Trials Network Women at Risk Committee . Preventing HIV infection in women. J Acquir Immune Defic Syndr. 2013, 63: S168-73 PMCID: 4084712
Aizire J, Fowler MG, Wang J, Shetty AK, Stranix-Chibanda L, Kamateeka M, Brown ER, Bolton SG, Musoke PM, Coovadia H . Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated. AIDS. 2012, 26: 325-33 PMCID: 3356697
Avery LB, Bakshi RP, Cao YJ, Hendrix CW . The male genital tract is not a pharmacological sanctuary from efavirenz. Clin Pharmacol Ther. 2011, 90: 151-56 PMCID: 3215581
Baeten JM, Haberer JE, Liu AY, Sista N . Preexposure prophylaxis for HIV prevention: where have we been and where are we going?. J Acquir Immune Defic Syndr. 2013, 63: S122-9 PMCID: 3710117
Baeten JM, Richardson BA, Martin HL Jr, Nyange PM, Lavreys L, Ngugi EN, Mandaliya K, Ndinya-Achola JO, Bwayo JJ, Kreiss JK . Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: implications for HIV-1 vaccine efficacy trials. Journal of AIDS. 2000, 24: 458-64
Balakrishnan P, Solomon S, Mohanakrishnan J, Cecelia AJ, Kumarasamy N, Murugavel KG, Venkatakrishnan B, Solomon SS, Crowe SM, Ganesh AK, Thyagarajan SP, Flanigan T, Mayer KH . A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings. J Acquir Immune Defic Syndr. 2006, 43: 23-6 PMID: 16885780
Barresi P, Husnik M, Camacho M, Powell B, Gage R, LeBlanc D, Verano P, Chesney M, Koblin B . Recruitment of men who have sex with men for large HIV intervention trials: analysis of the EXPLORE Study recruitment effort. AIDS Educ Prev. 2010, 22: 28-36 PMCID: 3114877
Batra M, Tien PC, Shafer RW, Contag CH, Katzenstein DA . HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe. AIDS Res Hum Retroviruses. 2000, 16: 973-9
Becker-Pergola G, Mellquist JL, Guay L, Mmiro F, Ndugwa C, Kataaha P, Jackson JB, Eshleman SH . Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women. AIDS Res Hum Retroviruses. 2000, 16: 1099-04
Bedoya CA, Mimiaga MJ, Beauchamp G, Donnell D, Mayer KH, Safren SA . Predictors of HIV transmission risk behavior and seroconversion among Latino men who have sex with men in Project EXPLORE. AIDS Behav. 2012, 16: 608-17 PMCID: 3632284
Belshe RB, Stevens C, Gorse GJ, Buchbinder S, Weinhold K, Sheppard H, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege AM, Harro C, Corey L, Keefer M, M . Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J Infect Dis. 2001, 183: 1343-52
Bentley ME, Fullem AM, Tolley EE, Kelly CW, Jogelkar N, Srirak N, Mwafulirwa L, Khumalo-Sakutukwa G, Celentano DD . Acceptabilty of a microbicide among women and their partners in a 4-country phase 1 trial. Am J Public Health. 2004, 94: 1159-64
Bentley ME, Morrow KM, Fullem A, Chesney MA, Horton SD, Rosenberg Z, Mayer KH . Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam Plann Perspect. 2000, 32: 184-8
Bentley ME, Spratt K, Shepherd ME, Gangakhedkar RR, Thilikavathi S, Bollinger RC, Mehendale SM . HIV testing and counseling among men attending STD clinics in Pune, India: Changes in condom use and sexual behavior over time. AIDS. 1998, 12: 1869-1877
Blackstock OJ, Frew P, Bota D, Vo-Green L, Parker K, Franks J, Hodder SL, Justman J, Golin CE, Haley DF, Kuo I, Adimora AA, Rompalo A, Soto-Torres L, Wang J, Mannheimer SB . Perceptions of Community HIV/STI Risk Among U.S Women Living in Areas with High Poverty and HIV Prevalence Rates.. J Health Care Poor Underserved. 2015, 26: 811-823
Blake DR, Maldeis N, Barnes MR, Hardick A, Quinn TC, Gaydos CA . Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transmitted Dis. 2008, 35: 649-655. PMCID: 2711851
Brahmi A, Reid C, Mass B, Kelly C . Meeting Retention Challenges in Lusaka Zambia. Research Practitioner. 2006, 7: 212-13
Branson BM, Viall A, Marum E . Expanding HIV testing: back to the future. J Acquir Immune Defic Syndr. 2013, 63: S117-21
Brewer RA, Magnus M, Kuo I, Wang L, Liu TY, Mayer KH . Exploring the relationship between incarceration and HIV among Black men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2013, 65: 218-25 PMCID: 3898433
Brewer RA, Magnus M, Kuo I, Wang L, Liu TY, Mayer KH . The high prevalence of incarceration history among black men who have sex with men in the United States: associations and implications. Am J Public Health. 2014, 104: 448-54
Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH . Estimation of HIV incidence using multiple biomarkers. Am J Epidemiol. 2013, 177: 264-72 PMCID: 3626051
Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH . Cross-sectional HIV incidence estimation in HIV prevention research. J Acquir Immune Defic Syndr. 2013, 63: S233-9 PMCID: 3737594
Brown E, Chi BH, Read JS, Taha T, Sharma U, Hoffman IF, Pikora C, Goldenberg RL, Fiscus S . Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period. AIDS. 2008, 22: 2341-6 PMCID:2760032
Brown EL, Wald A, Hughes JP, Morrow RA, Krantz E, Mayer K, Buchbinder S, Koblin B, Celum C . High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol. 2006, 164: 733-41 PMID 16896053
Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E . Determinants of Enrollment in a Preventive HIV Vaccine Trial: Hypothetical Versus Actual Willingness and Barriers to Participation. J Acquir Immune Defic Syndr. 2004, 36: 604-12
Caliendo AM, Valsamakis A, Bremer JW, Ferreira-Gonzalez A, Granger S, Sabatini L, Tosongalis GJ, Wang YF, Yen-Lieberman B, Young S, Lurain NS . Multilaboratory evaluation of real-time PCR tests for hepatitis B virus DNA quantification. J Clin Micro. 2011, 49: 2854-58 PMCID: 3147738
Cao H, Kaleebu P, Hom D, Flores J, Agrawal D, Jones N, Serwanga J, Okello M, Walker C, Sheppard H, El-Habib R, Klein M, Kebba A, Salata R, Mbidde E, Mugyenyi P, Walker B, Ellner J, Mugerwa R, and the HIV Network for Prevention Trials . Immunogenicity of a Recombinant Human Immunodeficiency Virus (HIV)-Canarypox Vaccine in HIV-Seronegative Ugandan Volunteers: Results of the HIV Network for Prevention Trials 007 Vaccine Study. J Infect Dis. 2003, 187: 887-95
Cao YJ, Caffo B, Choi L, Radebaugh CL, Fuchs EJ, Hendrix CW . Noninvasive quantitation of drug concentration in prostate and seminal vesicles: improvement and validation with desipramine and aspirin. J Clin Pharmacol. 2007, 48: 176-83
Cao YJ, Ndovi TT, Parsons TL, Guidos AM, Caffo B, Hendrix CW . Effect of semen sampling frequency on seminal antiretroviral drug concentration. Clin Pharmacol Ther. 2008, 83: 848-56
Carballo-Diéguez A, Balán IC, Morrow K, Rosen R, Mantell JE, Gai F, Hoffman S, Maslankowski L, El-Sadr W, Mayer K . Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050). AIDS Care. 2007, 19: 1026-31 PMID: 17852000
Casper C, Carrell D, Miller KG, Judson FD, Meier AS, Pauk JS, Morrow RA, Corey L, Wald A, Celum C . HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study. Sex Transm Infect. 2006, 82: 229-35 PMCID: 2564745
Casper C, Wald A, Pauk J, Tabet SR, Corey L, Celum CL . Correlates of prevalent and incident kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J Infect Dis. 2002, 185: 990-3
Cates W Jr, Allen M . Mother-to-child HIV-1 transmission. Lancet. 2000, 356: 945
Cavacini LA, Peterson JE, Nappi E, Duval M, Goldstein R, Mayer K, Posner MR . Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals. J Virol. 1999, 73: 9638-41
Celentano DD, Bond KC, Lyles CM, Eiumtrakul S, Go VF, Beyrer C, na Chiangmai C, Nelson KE, Khamboonruang C, Vaddhanaphuti C . Preventive intervention to reduce sexually transmitted infections: a field trial in the Royal Thai Army. Arch Intern Med. 2000, 160: 535-40
Celum C, Baeten JM, Hughes JP, Barnabas R, Liu A, Van Rooyen H, Buchbinder S . Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations. J Acquir Immune Defic Syndr. 2013, 63: S213-20 PMCID: 3708491
Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia, M, Ortiz A, Fuchs J, Buchbinder S, Koblin B, Zwerski S, Rose S, Wang J, Corey L, HPTN 039 Protocol Team . Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet. 2008, 371: 2109-19. PMCID:2650104
Celum CL, Buchbinder SP, Donnell D, Douglas JM Jr, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW . Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis. 2001, 183: 23-35
Chasela C, Chen YQ, Fiscus S, Hoffman I, Young A, Valentine M, Emel L, Taha TE, Goldenberg RL, Read JS . Risk Factors for Late Postnatal Transmission of Human Immunodeficiency Virus Type 1 in Sub-Saharan Africa. Pediatr Infect Dis J. 2008, 27: 251-6. PMCID: 2730543
Chen I, Clarke W, Ou SS, Marzinke MA, Breaud A, Emel LM, Wang J, Hughes JP, Richardson P, Haley DF, Lucas J, Rompalo A, Justman JE, Hodder SL, Eshleman SH . Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064. PLoS One. 2015, 10: e0140074
Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, Rio CD, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH . Antiretroviral drug use and HIV drug resistance among HIV-infected Black men who have sex with men: HIV Prevention Trials Network 061. J Acquir Immune Defic Syndr. 2015
Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Rio CD, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH . Low-level Viremia Early in HIV Infection. J Acquir Immune Defic Syndr. 2014, 67: 405-8
Chen I, Huang W, Connor MB, Frantzell A, Cummings V, Beauchamp GG, Griffith S, Fields SD, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH . CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061. HIV Clin Trials. 2016, 17: 158-64
Chen YQ, Masse B, Wang L, Ou SS, Li X, Donnell D, McCauley M, Gamble T, Ribauldo HJ, Cohen MS, Fleming TR . Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples. Contemp Clin Trials. 2012, 33: 1280-6 PMCID:3468650
Chen YQ, Young A, Brown ER, Chasela CS, Fiscus SA, Hoffman IF, Valentine M, Emel L, Taha TE, Goldenberg RL, Read JS . Population Attributable Fractions for Late Postnatal Mother-to-Child Transmission of HIV-1 in Sub-Saharan Africa. JAIDS. 2010, 54: 311-16 PMCID: 3086731
Chesney MA, Koblin BA, Barresi PJ, Husnik MJ, Celum CL, Colfax G, Mayer K, McKirnan D, Judson FN, Huang Y, Coates TJ . An Individually Tailored Intervention for HIV Prevention: Baseline Data From the EXPLORE Study. Am J Public Health. 2003, 93: 933-8
Chi BH, Wang L, Read JS, Sheriff M, Fiscus S, Brown ER, Taha TE, Valentine M, Goldenberg R . Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024. AIDS. 2005, 19: 1857-64
Chi BH, Wang L, Read JS, Taha TE, Sinkala M, Brown ER, Valentine M, Martinson F, Goldenberg RL . Predictors of stillbirth in sub-saharan Africa. Obstet Gynecol. 2007, 110: 989-97 PMID:17978109
Chilongozi D, Wang L, Brown L, Taha T, Valentine M, Emel L, Sinkala M, Kafulafula G, Noor RA, Read JS, Brown ER, Goldenberg RL, Hoffman I, HIVNET 024 Study Team . Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J. 2008, 27: 808-14 PMCID:2739309
Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, Da Costa M, Darragh T, Jones D Judson F, Koblin B, Mayer KH, Palefsky JM . Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS. 2009, 23: 1135-42 PMID: 19390418
Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, Da Costa M, Darragh T, Benet DJ, Judson F, Koblin B, Mayer KH, Palefsky JM . Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst. 2005, 97: 896-05
Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, Colfax G, Da Costa M, Darragh T, Hess E, Judson F, Koblin B, Madison M, Palefsky JM . Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis. 2004, 190: 2070-6 PMID: 19390418
Chingono A, Lane T, Chitumba A, Kulich M, Morin S . Balancing science and community concerns in resource-limited settings: Project Accept in rural Zimbabwe. Clin Trials. 2008, 5: 273-6 PMID:18559417
Chirowodza A, van Rooyen H, Joseph P, Sikotoyi S, Richter L, Coates T . Using Participatory Methods and Geographic Information Systems (Gis) to Prepare for an HIV Community-based Trial in Vulindlela, South Africa (Project Accept-HPTN 043. Journal of Community Psychology. 2009, 37: 41-57 PMCID:2747527
Christerson L, Bom RJM, Bruisten SM, Yass R, Hardick J, Bratt G, Gaydos CA, Morré SA, Herrmann B . Chlamydia trachomatis strains show specific clustering for men who have sex with men compared to heterosexual transmission in Sweden, the Netherlands, and the United States. J Clin Microbiol. 2012, 50: 3548-55 PMCID: 3486246
Church JD, Eshleman SH . Reply to Krivine et al. J Infect Dis. 2009, 199: 1554-5
Church JD, Huang W, Mwatha A, Musoke P, Jackson JB, Bagenda D, Omer SB, Donnell D, Nakabiito C, Eure C, Guay LA, Taylor A, Bakaki PM, Matovu F, McConnell M, Fowler MG, Eshleman SH . Analysis of HIV tropism in Ugandan infants. Curr HIV Res. 2010, 8: 498-503 PMCID: 3075545
Church JD, Huang W, Mwatha A, Toma J, Stawiski E, Donnell D, Guay LA, Mmiro F, Musoke P, Jackson JB, Parkin N, Eshleman SH . HIV-1 tropism and survival in vertically infected Ugandan infants. J Infect Dis. 2008, 197: 1382-8 PMCID: 3075545
Church JD, Huang W, Parkin N, Marlowe N, Guay LA, Omer SB, Musoke P, Jackson JB, Eshleman SH . Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. AIDS Res Hum Retroviruses. 2009, 25: 657-63 PMCID: 2799186
Church JD, Hudelson SE, Guay LA, Chen S, Hoover DR, Parkin N, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Eshleman SH . HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. AIDS Res Hum Retroviruses. 2007, 23: 764-68 PMID 17604538
Church JD, Jones D, Flys T, Hoover D, Marlowe N, Chen S, Shi C, Eshleman JR, Guay LA, Jackson JB, Kumwenda N, Taha TE, Eshleman SH . Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. J Mol Diagn. 2006, 8: 430-2 PMCID: 1867617
Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, and Eshleman SH . In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. AIDS Res Hum Retroviruses. 2009, 25: 673-7 PMCID: 2752753
Church JD, Omer SB, Guay LA, Huang W, Lidstrom J, Musoke P, Mmiro F, Jackson JB, Eshleman SH . Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. J Infect Dis. 2008, 198: 1075-1082 PMCID:2587235
Church JD, Towler WI, Hoover DR, Hudelson SE, Kumwenda N, Taha TE, Eshleman JR, Eshleman SH . Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants. AIDS Res Hum Retroviruses. 2008, 24: 595-605
Clarke J, Peipert JF, Hillier SH, Heber W, Boardman L, Moench TR, Mayer K . Microflora changes with the use of a vaginal microbicide. Sex Transm Dis. 2002, 29: 288-93
Closson E, Mimiaga M, Sherman S, Tangmunkongvorakul A, Friedman R, Limbada M, Moore A, Srithanaviboonchai K, Alves C, Roberts S, Oldenburg C, Elharrar V, Mayer K, Safren S, Tangmunkongvorakul A, Friedman R, Srithanaviboonchai K . Intimacy versus Isolation: A Qualitative Study of Sexual Practices among Sexually Active HIV-Infected Patients in HIV Care in Brazil, Thailand, and Zambia. PLoS One. 2015, 10
Coates T . An expanded behavioral paradigm for prevention and treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2013, 63: S179-82 PMCID:3943341
Coates TJ, Kulich M, Celentano D, Zelaya CE, Chariyalertsak S, Chingono A, Gray G, Mbwambo JK, Morin SF, Richter L, Sweat M, van Rooyen H, McGrath N, Fiamma A, Laeyendecker O, Piwowar-Manning E, Szekeres G, Donnell D, Eshleman SH; NIMH Project Accept Team, Eshleman SH, NIMH Project Accept Team . Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. Lancet Glob Health. 2014, 2: e267-77
Coates TJ, Richter L, Caceres C . Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008, 372: 669-84. PMCID:2702246
Cohen MS, Baden LR . Preexposure prophylaxis for HIV--where do we go from here?. N Engl J Med. 2012, 367: 459-61
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim J, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, et al . Prevention of HIV-1 infection with early antiretroviral therapy. NEJM. 2011, 365: 493-505 PMCID: 3200068
Cohen MS, Mastro TD, Cates W Jr . Universal Voluntary HIV Testing and Immediate Antiretroviral Therapy. Lancet. 2009, 373: 1077 (Published comment)
Cohen MS, McCauley M, Gamble TR . HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS. 2012, 7: 99-105 PMCID: 3486734
Cohen, MS, McCauley, M, Sugarman, J . Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey. Clin Trials. 2012, 9: 340-7 PMCID: 3486723
Coletti A, Heagerty P, Sheon A, Gross M, Koblin B, Metzger D, Seage G . Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine trials. J Acquir Immune Defic Syndr. 2003, 32: 161-9
Colfax G, Coates TJ, Husnik MJ, Huang Y, Buchbinder S, Koblin B, Chesney M, Vittinghoff E . Longitudinal patterns of methamphetamine, popper (Amyl Nitrite), and the cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. J Urban Health. 2005, 82: i62-i70
Colfax G, Vittinghoff E, Husnik MJ, McKirnan D, Buchbinder S, Koblin B, Celum C, Chesney M, Huang Y, Mayer K, Bozeman S, Judson FN, Bryant KJ, Coates TJ, EXPLORE study team . Substance Use and Sexual Risk: A Participant- and Episode-level Analysis among a Cohort of Men Who Have Sex with Men. Am J Epidemiol. 2004, 159: 1002-12
Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W, Nakabiito C, Msweli L, Kisenge R, Guay L, Mwatha A, Lynn D, Eshleman S, Richardson P, George K, Andrew P, Mofenson L, Zwerski S, Maldonado Y . Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet. 2012, 379: 221-8 PMCID: 3539769
Cori A, Ayles H, Beyers N, Schaap A, Floyd S, Sabapathy K, Eaton JW, Hauck K, Smith P, Griffith S, Moore A, Donnell D, Vermund SH, Fidler S, Hayes R, Fraser C; HPTN 071 PopART Study Team . HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One. 2014, 9: e84511
Corneli A, Pettifor A, Kamanga G, Golin C, McKenna K, Ou SS, Hamela G, Massa C, Martinson F, Tharaldson J, Hilgenberg D, Yu X, Chege W, Hoffman I; HPTN 062 study team, Hoffman I, HPTN 062 study team . HPTN 062: A Feasibility and Acceptability Pilot Intervention to Reduce HIV Transmission Risk Behaviors Among Individuals with Acute and Early HIV Infection in Lilongwe, Malawi. AIDS Behav. 2014, 18: 1785-800
Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH . HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm. J Clin Microbiol. 2014, 52: 115-21
Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH . HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm. J Clin Microbiol. 2014, 52: 115-21
Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Kobin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH . A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. PLoS One. 2014, 9: e101043
Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR III, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH . A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. PLoS One. 2014, 9: e101043 PMCID: 4072769
Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, Khaki L, Koblin B, Chesney M, Moore RD, Kelen GD, Coates T, Celum C, Buchbinder SP, Seage GR, Quinn TC, Donnell D, and Eshleman SH . Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One. 2011, 6: e27211 PMCID: 3206918
Cousins MM, Ou SS, Wawer MJ, Munshaw S, Swan D, Magaret CA, Mullis CE, Serwadda D, Porcella SF, Gray RH, Quinn TC, Donnell D, Eshleman SH, Redd AD . Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity. J Clin Microbiol. 2012, 50: 3054-9 PMCID: 3421787
Cunha CB, Friedman RK, de Boni RB, Gaydos C, Guimarães MR, Siqueira BH, Cardoso SW, Chicayban L, Coutinho JR, Yanavich C, Veloso VG, Grinsztejn B . Chlamydia trachomatis, Neisseria gonorrhoeae and syphilis among men who have sex with men in Brazil. BMC Public Health. 2015, 15: 686
Cunningham S, Ank B, Lewis D, Wei L, Wantman W, Dileanis J, Jackson JB, Palumbo P, Krogstad P, and Eshleman SH . Performance of the Applied Biosystems ViroSeq HIV-1 Genotyping System for analysis of HIV-1 in pediatric plasma samples. J Clin Microbiology. 2001, 39: 1254-7
Curlin ME, Cassis-Ghavami F, Magaret AS, Spies GA, Duerr A, Celum CL, Sanchez JL, Margolick JB, Detels R, McElrath MJ, Corey L . Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study. AIDS. 2011, 25: 153-8 PMCID: 3057418
Dai JY, Gilbert PB, Mâsse BR . Partially hidden Markov model for time-varying principal stratification in HIV prevention trials. J Am Stat Assoc. 2012, 107: 52-65 PMCID: 3649016
Daley T . Impact of traditional healers on clinical research in Tanzania. Research Practitioner. 2006, 7: 216
Daniels J, Komárek A, Makusha T, Van Heerden A, Gray G, Chingono A, Mbwambo JK, Coates T, Richter L . Effects of a community intervention on HIV prevention behaviors among men who experienced childhood sexual or physical abuse in four African settings: findings from NIMH Project Accept (HPTN 043). PLoS One. 2014, 9: e99643
DeMaria, Jr, A, Kunches L, Mayer K, Cohen C, Epstein P, Werner B, Day J, DeCristofaro J, Landers S, Tang Y, Coady W, and the Massachusetts gp160 Working Group . Immune Responses to a Recombinant Human Immunodeficiency Virus Type 1 (HIV-1) gp160 Vaccine Among Adults with Advanced HIV Infection. J Hum Virol. 2000, 3: 182-92
Des Jarlais DC, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, Torian L, Glebatis D, Murrill C, Monterroso E, Friedman SR . HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000, 90: 352-9
Dhawan D, Mayer KH . Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection. J Infect Dis. 2006, 193: 36-44 PMID: 16323129
Donnell D, Hughes J, Fleming TR . Challenges in the Design of HIV Prevention Trials in the United States. JAIDS. 2010, 55: S136-S140 PMCID: 3298818
Donnell D, Hughes JP, Wang L, Chen YQ, Fleming TR . Study design considerations for evaluating efficacy of systemic preexposure prophylaxis interventions. J Acquir Immune Defic Syndr. 2013, 63: S130-4 PMCID: 3725298
Donnell DJ, Hall I, Gamble T, Beauchamp G, Griffin AB, Torian LV, Branson B . Use of HIV Case Surveillance System to design and evaluate site-randomized interventions in an HIV prevention study: HPTN 065. Open AIDS J. 2012, 6: 122-30 PMCID: 3462339
El-Sadr WM, Affrunti M, Gamble T, Zerbe A . Antiretroviral therapy: a promising HIV prevention strategy?. J Acquir Immune Defic Syndr. 2010, 55 Suppl 2: S116-21
El-Sadr WM, Affrunti M, Gamble T, Zerbe A . Antiretroviral therapy: a promising HIV prevention strategy?. J Acquir Immune Defic Syndr. 2011, 55: 116-21 PMCID: 3074403
El-Sadr WM, Mayer KH, Maslankowski L, Hoesley C, Justman J, Gai F, Mauck C, Absalon J, Morrow K, Masse B, Soto-Torres L, Kwiecien A and the HPTN 049 Team . Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS. 2006, 20: 1109-16 PMID: 16691061
El-Sadr WM, Serwadda DM, Sista N, Cohen MS . HIV prevention: great achievements, more challenges ahead. J Acquir Immune Defic Syndr. 2013, 63: S115-6 PMCID: 3717370
Eshleman SH, Becker-Pergola G, Deseyve M, Guay LA, Mracna M, Fleming T, Cunningham S, Musoke P, Mmiro F, Jackson JB . Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study). J Infect Dis. 2001, 184: 914-7
Eshleman SH, Church JD, Chen S, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Hoover DR . Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D. J Acquir Immune Defic Syndr. 2006, 42: 518-21 PMID 16810119
Eshleman SH, Crutcher G, Petrauskene O, Kunstman K, Cunningham SP, Trevino C, Davis C, Kennedy J, Fairman J, Foley B, Kop J . Sensitivity and specificity of the ViroSeq® HIV-1 Genotyping System for detection of HIV-1 drug resistance mutations using an ABI PRISM® 3100 Genetic Analyzer. J Clin Micro. 2005, 43: 813-17 PMCID: 548107
Eshleman SH, Gonzales MJ, Becker-Pergola G, Cunningham SC, Guay LA, Jackson JB, Shafer RW . Identification of Ugandan HIV Type 1 Variants with Unique Patterns of Recombination in pol Involving Subtypes A and D. AIDS Res Hum Retroviruses. 2002, 18: 507-11
Eshleman SH, Guay LA, Fleming T, Mwatha A, Mracna M, Becker-Pergola G, Musoke, Mmiro F, Jackson JB . Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012). J Acquir Immune Defic Syndr. 2002, 31: 327-30
Eshleman SH, Guay LA, Mwatha A, Brown ER, Cunningham SP, Musoke P, Mmiro F, Jackson JB . Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).. J Acquir Immune Defic Syndr. 2004, 35: 126-30
Eshleman SH, Guay LA, Mwatha A, Cunningham SP, Brown ER, Musoke P, Mmiro F, Jackson JB . Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012. AIDS Res Hum Retroviruses. 2004, 20: 595-99
Eshleman SH, Guay LA, Wang J, Mwatha A, Brown ER, Musoke P, Mmiro F, Jackson JB . Distinct Patterns of Emergence and Fading of K103N and Y181C in Women With Subtype A vs. D After Single-Dose Nevirapine: HIVNET 012. J Acquir Immune Defic Syndr. 2005, 40: 24-9
Eshleman SH, Hoover DR, Chen S, Hudelson SE, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Jackson JB, Kumwenda N, Taha T . Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. J Infect Dis. 2005, 192: 30-6
Eshleman SH, Hoover DR, Chen SH, Hudelson SH, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Jackson JB, Kumwenda N, and Taha T . Resistance after single dose nevirapine prophylaxis emerges in a high portion of Malawian newborns. AIDS. 2005, 19: 2167-68
Eshleman SH, Hoover DR, Hudelson SE, Chen S, Fiscus SA, Piwowar-Manning E, Jackson JB, Kumwenda NI, Taha T . Development of nevirapine resistance is reduced by using infant-only nevirapine plus zidovudine post-exposure prophylaxis to prevent HIV-1 mother–to-child transmission. J Infect Dis. 2006, 193: 479-81 PMID:16425125
Eshleman SH, Hudelson S, Gupta A, Bollinger R, Divekar AD, Gangakhedkar RR, Kulkarni SS, Thakar MR, Paranjape RS, and Tripathy S . Limited evolution in the HIV-1 pol region among acute seroconverters in Pune, India. AIDS Res Hum Retroviruses. 2005, 21: 93-97
Eshleman SH, Hudelson SE, Bruce R, Lee T, Owens MR, Hackett J, Swanson P, Devare SG, and Marlowe N . Analysis of HIV type 1 gp41 sequences in diverse HIV type 1 strains. AIDS Res Hum Retroviruses. 2007, 23: 1593-8
Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou S-S, Zhang C, Ping L-H, Piwowar-Manning E, Porcella SF, Sievers MF, Martens CA, Bruno D, Dukhovlinova E, McCauley M, Gamble T, Fogel JM, Sabin D, Quinn TC, Gunde L, Maliwichi M, Nhando N, Akelo V, Moyo S, Panchia R, Kumarasamy N, Chotirosniramit N, Gonçalves de Melo M, Pilotto J, Grinsztejn B, Mayer K, Chen YQ, Hughes JP, Cohen MS . Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial.. J Acquir Immune Defic Syndr.
Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF, Munshaw S, Ray SC, Piwowar-Manning E, McCauley M, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, de Bruyn G, Grinsztejn B, et al . Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis. 2011, 204: 1918-26 PMCID: 3209811
Eshleman SH, Hudelson SE, Smith P, Hackett J, Holzmayer V, Swanson P, Devare SG, Marlowe N . Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. AIDS Res Hum Retroviruses. 2009, 25: 343-5 PMCID: 2853838
Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, Johnson-Lewis L, Mullis CE, Hackett J Jr, Vallari AS, Justman J, Hodder S . Use of a multi-faceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis. 2013, 207: 223-31 PMCID: 3532822
Eshleman SH, Husnik M, Hudelson S, Donnell D, Huang Y, Huang W, Hart S, Jackson JB, Coates T, Chesney M, and Koblin B . Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. AIDS. 2007, 21: 1165-74 PMID: 17502727
Eshleman SH, Jackson JB . Nevirapine resistance after single dose prophylaxis. AIDS Reviews. 2002, 4: 59-63
Eshleman SH, Jones D, Flys T, Petrauskene O, and Jackson JB . Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq HIV-1 Genotyping System. Biotechniques. 2003, 35: 614-8, 620, 622
Eshleman SH, Jones D, Galovich J, Paxinos EE, Petropoulos CJ, Jackson JB, Parkin N . Phenotypic Drug Resistance Patterns in Subtype A HIV-1 Clones with Nonnucleoside Reverse Transcriptase Resistance Mutations. AIDS Res Hum Retroviruses. 2006, 22: 289-93 PMID:16545016
Eshleman SH, Khaki L, Laeyendecker O, Piwowar-Manning E, Johnson-Lewis L, Husnik M, Koblin B, Coates T, Chesney M, Vallari A, Devare SG, Hackett J Jr . Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr. 2009, 52: 121-4 PMCID: 2744045
Eshleman SH, Laeyendecker O, Parkin N, Huang W, Chappey C, Paquet AC, Serwadda D, Reynolds SJ, Kiwanuka N, Quinn TC, Gray R, Wawer M . Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda. AIDS. 2009, 27: 845-52 PMCID:2676205
Eshleman SH, Lie Y, Hoover DR, Chen S, Hudelson SE, Fiscus SA, Petropoulos CJ, Kumwenda N, Parkin N, and Taha TE . Association between the replication capacity and mother-to-child transmission of HIV-1, in antiretroviral drug-naïve Malawian women. J Infect Dis. 2006, 193: 1512-5 PMID:16652278
Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Glenn Fowler M, Mofenson LM, Mmiro F, Jackson JB . Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS. 2001, 15: 1951-7
Fiamma A, Lissouba P, Amy OE, Singh B, Laeyendecker O, Quinn TC, Taljaard D, Auvert B . Can HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265). BMC Infect Dis. 2010, 10: 137-46 PMCID: 2890001
Fleming TR, Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Grinsztejn B, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, Makhema J, Mills LA, Panchia R, Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano DD, Essex M, Hudelson SE, Redd AD, Pilotto JHS . Antiretroviral Therapy for the Prevention of HIV-1 Transmission. JAIDS. 2016, 375: 830-9
Fleming TR, Richardson BA . Some design issues in trials of microbicides for the prevention of HIV infection. J Infect Dis. 2004, 190: 666-74
Flys T, Marlowe N, Hackett J, Parkin N, Schumaker M, Holzmayer V, Hay P, and Eshleman SH . Analysis of PTAP duplications in the gag p6 region of subtype C HIV-1. AIDS Res Hum Retroviruses. 2005, 21: 739-41
Flys T, Nissley DV, Claasen CW, Jones D, Shi C, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH . Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. J Infect Dis. 2005, 192: 24-9
Flys TS, Chen S, Jones DC, Hoover DR, Church JD, Fiscus SA, Mwatha A, Guay LA, Mmiro F, Musoke P, Kumwenda N, Taha TE, Jackson JB, Eshleman SH . Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. J Acquir Immune Defic Syndr. 2006, 42: 610-13 PMID 16773030
Flys TS, Donnell D, Mwatha A, Nakabiito C, Musoke P, Mmiro F, Jackson JB, Guay LA, Eshleman SH . Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. J Infect Dis. 2007, 195: 711-5 PMID 17262714
Flys TS, McConnell MS, Matovu F, Church JD, Bagenda D, Khaki L, Bakaki P, Thigpen MC, Eure C, Fowler MG, Eshleman SH . Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission. J Infect Dis. 2008, 198: 465-9. PMCID:2640946
Flys TS, Mwatha A, Guay LA, Nakabiito C, Donnell D, Musoke P, Mmiro F, Jackson JB, and Eshleman SH . Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine. AIDS. 2007, 21: 2077-82 PMID 17885298
Fogel J, Hoover DR, Sun J, Mofenson LM, Fowler MG, Taylor AW, Kumwenda N, Taha TE, Eshleman SH . Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis. AIDS. 2011, 25: 911-17 PMCID: 3261770
Fogel J, Li Q, Taha TE, Hoover DR, Kumwenda NI, Mofenson LM, Kumwenda JJ, Fowler MG, Thigpen MT, Eshleman SH . Initiation of antiretroviral treatment in women after delivery can induce multi-class drug resistance in breastfeeding HIV-infected infants. Clin Infect Dis. 2011, 52: 1069-76 PMCID: 3070029
Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, Gallant JE, Kumwenda J, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim J, Badal-Faesen S, Akelo V, Hosseinipour MC, Santos BR, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Mayer KH, Chen YQ, Cohen MS, Eshleman SH . HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial.
Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH . Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-Infected Breastfeeding Infants. Pediatr Infect Dis J. 2013, 32: e164-9 PMCID: 3826537
Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH . Determination of HIV Status in African Adults With Discordant HIV Rapid Tests. J Acquir Immune Defic Syndr. 2015, 69: 430-8
Fogel JM, Taha TE, Sun J, Hoover DR, Parsons TL, Kumwenda JJ, Mofenson LM, Fowler MG, Hendrix CW, Kumwenda NI, Eshleman SH, Mirochnick M . Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants. J Acquir Immune Defic Syndr. 2012, 60: 462-5 PMCID: 3404155
Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Kumarasamy N, Grinsztejn B, Makhema J, Pilotto J, Santos BR, Mayer KH, McCauley M, Gamble T, et. Al . Undisclosed antiretroviral drug use in a multi-national clinical trial (HPTN 052). J Infect Dis. 2013, 208: 1624-8 PMCID: 3805242
Fouda GG, Yates NL, Pollara J, Shen X, Overman GR, Mahlokozera T, Wilks AB, Kang HH, Salazar-Gonzalez JF, Salazar MG, Kalilani L, Meshnick SR, Hahn BH, Shaw GM, Lovingood RV, Denny TN, Haynes B, Letvin NL, Ferrari G, Montefiori DC, Tomaras GD, Permar SR . HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies. J of Virol. 2011, 85: 9555-67 PMCID: 3165739
Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, et.al, Zwerski S, Mofenson LM, Jackson JB, HPTN 046 Protocol Team . Efficacy and Safety of an Extended Nevirapine Regimen in Infants of Breastfeeding Mothers With HIV-1 Infection for Prevention of HIV-1 Transmission (HPTN 046): 18-Month Results of a Randomized, Double-Blind, Placebo-Controlled Trial. J Acquir Immune Defic Syndr. 2014, 65: 366-74 PMCID: 3945386
Fuchs J, Celum C, Wang J, Hughes J, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A; HIV Prevention Trials Network 039 Protocol Team . Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J Infect Dis. 2010, 201: 1164-8 PMCID: 2856478
Gadkari DA, Quinn TC, Mehendale SM, Gangakhedkar RR, Divekar AD, Risbud AR, Chan-Tack K, Shepherd M, Gaydos C, Bollinger RC . HIV-1 DNA Shedding in Genital Ulcers and its Asscociated Risk Factors in Pune, India. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 18: 277-281
Gamiel JL, Tobian AA, Laeyendecker OB, Reynolds SJ, Ashley-Morrow R, Swerwadda D, Gray RH, and Quinn TC . Improved performance of enzyme linked immunosorbent assays and the effect of human immunodeficiency virus co-infection on the serologic detection of herpes simplex virus type-2 in Rakai Uganda. Clin Vaccine Immunol. 2008, 15: 888-890 PMCID:394849
Ganzura L, Latif A, Bassett M, Machekano R, Katzenstein DA, Mason PR . Syphilis serology and HIV infection in Harare, Zimbabwe. Sex Transm Infect. 1999, 75: 426-30
Gard CC, Brown ER . A coarsened multinomial regression model for perinatal mother to child transmission of HIV. BMC Med Res Methodol. 2008, 8: 46. PMCID:2515333
Gaydos C, Hardick J . Point of care diagnostics for sexually transmitted infections: perspectives and advances. Expert Rev Anti Infect Ther. 2014, 12: 657-72 PMCID: 4065592
Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC . Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis. 2009, 36: 598-606 PMCID: 2924808
Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC . Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics. Sex Transm Infect. 2009, 85: 438-40 PMCID: 2761964
Gaydos CA, Barnes M, Aumakhan B, Quinn N, Wright C, Agreda P, Whittle P, and Hogan T . Chlamydia trachomatis age-specific prevalence in women who used an internet-based self-screening program compared to women who were screened in family planning clinics. Sex Transm Dis. 2011, 38: 74-8 PMCID: 3187773
Gaydos CA, Crotchfelt KA, Shah N, Tennant M, Quinn TC, Gaydos JC, McKee KT, Rompalo AM . Evaluation of dry and wet transported intravaginal swabs to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections by PCR in female soldiers. J Clin Microbiol. 2002, 40: 758-61
Gaydos CA, Farshy C, Barnes M, Quinn N, Agreda P, Rivers CA, Schwebke J, Papp J . Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests?. Diag Microbiol Infect Dis. 2012, 73: 16-20 PMCID: 3425852
Gaydos CA, Hsieh Y-H, Barnes M, Quinn N, Agreda P, Jett-Goheen M, Whittle P, Hogan T . Trichomonas vaginalis infection in women who submit self-collected vaginal samples after internet recruitment. Sex Transm Dis. 2011, 38: 828-32 PMCID: 3157012
Gaydos CA, Rizzo-Price P, Balakrishnan P, Mateta SR, Leon S, Yin Y-P, Quinn TC, Strader LC, Pequegnat W . For the NIMH Collaborative HIV/STD Prevention Trial Group. Impact of international laboratory partnerships on the performance of HIV/STD testing in five resource constrained countries. Int J STD AIDS. 2011, 22: 645-52 PMCID: 3274418
Gaydos CA, Wright C, Wood BJ, Waterfield G, Hobson S and Quinn TC . Chlamydia trachomatis reinfection rates amoung female adolescents seeking rescreening in school-based health centers. Sex Transmit Dis. 2008, 35: 233-7 PMCID:2664683
Gaydos, CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero, Schachter J . Performance of the APTIMA Combo 2 assay for the multiplex detection of Chlamydia trachomatis and Neisseria gonorrheae in female urine and endocervical swab specimens. J Clin Microbiol. 2003, 41: 304-9
Genberg BL, Hlavka Z, Konda KA, Maman S, Chariyalertsak S, Chingono A, Mbwambo J, Modiba P, Van Rooyen H, Celentano DD . A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med. 2009, 68: 2279-87 PMID:19427086
Genberg BL, Kawichai S, Chingono A, Sendah M, Chariyalertsak S, Konda KA, Celentano DD . Assessing HIV/AIDS Stigma and Discrimination in Developing Countries. AIDS Behav. 2008, 12: 772-80 PMCID: 2745205
Genberg BL, Kulich M, Kawichai S, Modiba P, Chingono A, Kilonzo GP, Richter L, Pettifor A, Sweat M, Celentano DD; NIMH Project Accept Study Team (HPTN 043) . HIV Risk Behaviors in Sub-Saharan Africa and Northern Thailand: Baseline Behavioral Data From Project Accept. JAIDS. 2008, 49: 309-19. PMCID:2643066
Godbole S, Ghate M . Issues in managing and coordinating clinical research in India. Research Practitioner. 2006, 7: 219-20
Goldenberg RL, Andrews WW, Hoffman I, Fawzi W, Valentine M, Young A, Read JS, Brown ER, Mudenda V, Kafulafula G, Mwinga K, Taha TE . Fetal Fibronectin and Adverse Pregnancy Outcomes in a Predominantly HIV-infected African Population. Obstet Gynecol. 2007, 109: 392-401 PMID: 17267841
Goldenberg RL, Mudenda V, Read JS, Brown ER, Sinkala M, Kamiza S, Martinson F, Kaaya E, Hoffman I, Fawzi W, Valentine M, Taha TE; HPTN 024 Study Team . Histologic Chorioamnionitis, Antibiotics and Adverse Infant Outcomes in a Predominantly HIV-1-Infected African Population. Am J Obstet Gynecol. 2006, 195: 1065-74 PMID: 16875654
Goldenberg RL, Mwatha A, Read JS, Adeniyi-Jones S, Sinkala M, Msmanga G, Martinson F, Hoffman I, Fawzi W, Valentine M, Emel L, Brown E, Mudenda V, Taha TE; HPTN024 Team . The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol. 2006, 194: 650-61 PMID:16522393
Golin CE, Haley DF, Wang J, Hughes JP, Kuo I, Justman J, Adimora AA, Soto-Torres L, O'Leary A, Hodder S . Post-traumatic Stress Disorder Symptoms and Mental Health over Time among Low-Income Women at Increased Risk of HIV in the U.S.. J Health Care Poor Underserved. 2016, 27: 891-910
Golub SA, Rosenthal L, Cohen DE and Mayer KH . Determinants of High-Risk Sexual Behavior During Post-Exposure Prophylaxis to Prevent HIV Infection. AIDS Behav. 2008, 12: 852-9 PMID:17682938
Gorbach PM, Kelly CW, Borgerding JA, Ramjee G, Tembo T, Kumwenda N, Musara P, Roberts S, Maslankowski L . Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035). AIDS Behav. 2014, 18: 855-61
Gorbach PM, Mensch BS, Husnik M, Coly A, Mâsse B, Makanani B, Nkhoma C, Chinula L, Tembo T, Mierzwa S, Reynolds K, Hurst S, Coletti A, Forsyth A . Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial. AIDS Behav. 2013, 17: 790-800
Goulder PJ, Tang Y, Brander C, Betts M, Altfeld M, Annamalai K, Trocha A, He S, Rosenberg E, Ogg G, O’Callaghan CA, Kalams SA, McKinney, Jr. RE, Mayer K, Koup RA, Pelton SI, Burchett SK, McIntosh K, Walker BD . Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med. 2000, 192: 1819-32
Gregson S, Machekano R, Donnelly CA, Mbizvo MT, Anderson RM, Katzenstein DA . Estimating HIV incidence from age-specific prevalence data: comparison of concurrent cohort estimates in a study of male factory workers, Harare, Zimbabwe. AIDS. 1998, 12: 2049-58
Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, Godbole SV, Chariyalertsak S, et.al, de Melo MG, Mayer KH, Eshleman SH, Piwowar-Manning E, Makhema J, Mills LA, Panchia R, Sanne I, Gallant J, Hoffman I, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Havlir D, Cohen MS, HPTN 052-ACTG Study Team . Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014, 14: 281-90 PMCID: 4144040
Gross M, Buchbinder SP, Celum C, Heagerty P, Seage GR, 3rd . Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team.. Sex Transm Dis. 1998, 25: 296-302
Gross M, Buchbinder SP, Holte S, Celum CL, Koblin BA, Douglas JM, Jr . Use of reality female condoms for anal sex by US men who have sex with men. HIVNET Vaccine Preparedness Study Protocol Team. Am J Public Health. 1999, 89: 1739-41
Gross M, Celum CL, Tabet SR, Kelly CW, Coletti AS, Chesney MA . Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide. Sex Transm Dis. 1999, 26: 572-578
Gross M, Holte S, Seage GR 3rd, Buchbinder SP, Metzger DS, Mayer KH . Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations. AIDS Educ Prev. 2000, 12: 71-8
Gross M, Holte SE, Marmor M, Mwatha A, Koblin BA, Mayer KH . Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. J Acquir Immune Defic Syndr. 2000, 24: 393-8
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB . Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999, 354: 795-802
Guffey MB, Richardson B, Husnik M, Makanani B, Chilongozi D, Yu E, Ramjee G, Mgodi N, Gomez K, Hillier SL, Karim SA; HIV Prevention Trials Network (HPTN) 035 Study Team, Karim SA, HIV Prevention Trials Network (HPTN) 035 Study Team . HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women. Sex Transm Infect. 2014, 90: 363-9
Gupta A, Saple DG, Nadkarni G, Shah B, Vaidya S, Hingankar N, Chaturbhuj D, Deshmukh P, Walshe L, Hudelson SE, James M, Paranjape RS, Eshleman SH, Tripathy S . One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. AIDS Res Hum Retroviruses. 2010, 26: 25-31 PMCID: 2858895
Gwanzura L, McFarland W, Alexander, Burke RL, Katzenstein DA . Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis. 1998, 177: 481-4
Haley DF, Golin C, El-Sadr W, Hughes JP, Wang J, Roman Isler M, Mannheimer S, Kuo I, Lucas J, DiNenno E, Justman J, Frew PM, Emel L, Rompalo A, Polk S, Adimora AA, Rodriquez L, Soto-Torres L, Hodder S . Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study. J Womens Health (Larchmt). 2014, 23: 541-51
Haley DF, Justman JE . The HIV epidemic among women in the United States: a persistent puzzle. J Womens Health. 2013, 22: 715-7
Haley DF, Lucas J, Golin CE, Wang J, Hughes JP, Emel LM, El-Sadr W, Frew PM, Justman J, Adimora AA, Watson CC, Mannheimer S, Rompalo A, Soto-Torres L, Tims-Cook Z, Carter Y, Hodder SL, HPTN 064 Study Team . Retention Strategies and Factors Associated with Missed Visits Among Low Income Women at Increased Risk of HIV Acquisition in the US (HPTN 064. AIDS Patient CARE STDS. 2014, 28: 206-17
Hall G, Li K, Wilton L, Wheeler D, Fogel J, Wang L, Koblin B, Fogel J . A Comparison of Referred Sexual Partners to Their Community Recruited Counterparts in The BROTHERS Project (HPTN 061). AIDS and Behavior. 2015, 19: 2214-23
Halperin DT, Weiss HA, Hayes R, Auvert B, Bailey RC, Caldwell J, Coates T, Padian N, Potts M, Ronald A, Short R, Williams B, Klausner J . Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381). AIDS. 2002, 16: 810-2
Halpern SD, Metzger DS, Berlin JA, Ubel PA . Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr. 2001, 27: 281-8
Hanrahan D, Sexton P, Hui K, Teitcher J, Sugarman J, London AJ, Barnes M, Purpura J, Klitzman R . Linguistic and Cultural Challenges in Communication and Translation in US-Sponsored HIV Prevention Research in Emerging Economies. PLoS One. 2015, 10: e01333394
Harawa N, Wilton L, Wang L, Mao C, Kuo I, Penniman T, Shoptaw S, Griffith S, Williams JK, Cummings V, Mayer K, Koblin B; HPTN 061 Study Team, Koblin B, HPTN 061 Study Team . Types of Female Partners Reported by Black Men Who Have Sex with Men and Women (MSMW) and Associations with Intercourse Frequency, Unprotected Sex and HIV and STI Prevalence. AIDS Behav. 2014, 18: 1548-59
Harrison LH, do Lago RF, Friedman, RK, Rodrigues L, Santos EM, de Melo MF, Moulton LH, Schechter, M . Incident HIV Infection in a high- risk, homosexual male cohort in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 1999, 21: 408-12
Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, Bock P, Griffith S, Moore A, Watson-Jones D, Fraser C, Vermund SH, Fidler S; HPTN 071 (PopART) Study Team, Fidler S, HPTN 071 (PopART) Study Team . HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial. Trials. 2014, 15: 57 PMCID: 3929317
Hayes R, Fidler S, Cori A, Fraser C, Floyd S, Ayles H, Beyers N, El-Sadr W; HPTN 071 (PopART) Study Team, El-Sadr W, HPTN 071 (PopART) Study Team . HIV Treatment-As-Prevention Research: Taking the Right Road at the Crossroads. PLoS Med. 2015, 12
Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, Griffith S, Donnell D, Piwowar-Manning E, El-Sadr W, Beyers N, Ayles H, Fidler S, HPTN 071 (PopART) Study Team . A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.. PLoS Med. 2017, 14: e1002292
Heimer R, Barbour R, Shaboltas AV, Hoffman IF, Kozlov AP . Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission. AIDS. 2008, 22: 123-30. PMCID:2778790
Hendriksen ES, Hlubinka D, Chariyalertsak S, Chingono A, Gray G, Mbwambo J, Richter L, Kulich M, Coates TJ . Keep Talking About It: HIV/AIDS-Related Communication and Prior HIV Testing in Tanzania, Zimbabwe, South Africa, and Thailand. AIDS Behav. 2009, 13: 1213-21 PMCID: 2866302
Hendrix CW, Andrade A, Bumpus NN, Kashuba AD, Marzinke MA, Moore A, Anderson PL, Bushman LR, Fuchs EJ, Wiggins I, Radebaugh C, Prince HA, Bakshi RP, Wang R, Richardson P, Shieh E, McKinstry L, Li X, Donnell D, Elharrar V, Mayer KH, Patterson KB . Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066). AIDS Res Hum Retroviruses. 2016, 32: 32-43
Hendrix CW, Cao YJ, Fuchs EJ . Topical microbicides to prevent HIV: clinical drug development challenges. Annu Rev Pharmacol Toxicol. 2009, 49: 349-75 PMID:19006450
Hirschhorn L, Kunches L, Mayer K . Nonoccupational Postexposure Prophylaxis. Evolving Clinical Practice. AIDS Clinical Care. 2000, 12: 6-12
Hodder SL, Justman J, Haley DF, Adimora AA, Fogel CI, Golin CE, O'Leary A, Soto-Torres L, Wingood, G, El-Sadr WM Behalf of the HIV Prevention Trials Network, Domestic Prevention Working Group (HPTN DPWG) Women at Risk Group . Challenges of a Hidden Epidemic: HIV Prevention Among Women in the United States. JAIDS. 2010, 55: S69-S73 PMCID: 3551266
Hodder SL, Justman J, Hughes JP, Wang J, Haley DF, Adimora AA, Del Rio C, Golin CE, Kuo I, Rompalo A, Soto-Torres L, Mannheimer SB, Johnson-Lewis L, Eshleman SH, El-Sadr WM for HPTN 064, the Women's SeroIncidence Study Team . HIV Acquisition Among Women From Selected Areas of the
United States: A Cohort Study
. Ann Intern Med. 2013, 158: 10-18 PMCID: 4033695
Hofer CB, Harrison LH, Struchiner CJ, Moreira RI, do Lago RF, de Melo MF, Schechter M . Acute retrovirus syndrome among prospectively identified homosexual men with incident HIV infection in Brazil. The Projecto Praca Onze Study Group. Journal of Acquired Immune Deficiency Syndrome. J Acquir Immune Defic Syndr. 2000, 25: 188-91
Hoffman IF, Taha TE, Padian NS, Kelly CW, Welch JD, Martinson FE, Kumwenda NI, Rosenberg ZF, Chilongozi DA, Brown JM, Chirenje M, Richardson BA . Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa. AIDS. 2004, 18: 2191-5
Hsieh YH, Gaydos CA, Hogan MT, Jackman J, Jett-Goheen M, Uy OM, Rompalo AM . Perceptions on point-of-care tests for sexually transmitted infections – Comparison between frontline clinicians and professionals in industry. Point Care. 2012, 11: 126-9 PMCID: 3404836
Hsieh YH, Gaydos CA, Hogan MT, Uy OM, Jackman J, Jett-Goheen M, Albertie A, Dangerfield DT 2nd, Neustadt CR, Wiener ZS, Rompalo AM . What qualities are most important to making a point of care test desirable for clinicians and others offering sexually transmitted infection testing?. PLoS One. 2011, 6: e19263 PMCID: 3084795
Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnell D, Mmiro F, Musoke P, Guay LA, Jackson JB, Parkin NT, Petropoulos CJ . Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol. 2007, 81: 7885-93 PMCID: 1951291
Huang W, Eshleman SH, Toma J, Stawiski E, Whitcomb JM, Jackson JB, Guay L, Musoke P, Parkin N, Petropoulos CJ . Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs. AIDS. 2009, 23: 1903-8 PMCID: 2764460
Huang W, Toma J, Stawiski E, Fransen S, Wrin T, Parkin N, Whitcomb JM, Coakley E, Hecht FM, Deeks SG, Gandhi RT, Eshleman SH, Petropoulos CJ . Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals. AIDS Res Hum Retroviruses. 2009, 25: 795-802 PMCID: 2827835
Hudelson SE, Marlowe N, Huang W, Bruce R, Church JD, Husnik M, Donnell D, Coates T, Jackson JB, Chesney M, Koblin B Eshleman SH . Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors. AIDS Res Hum Retroviruses. 2009, 25: 701-5 PMCID: 2746939
Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, Bakaki PM, Thigpen MC, Mubiru M, Fowler MG, Eshleman SH . Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS. 2010, 24: 557-61 PMCID: 3065236
Hughes JP, Goldenberg R, Wilfert CM, Valentine M, Mwinga KG . Design of the HIV Prevention Trials Network (HPTN) Protocol 054: A cluster randomized crossover trial to evaluate combined access to nevirapine in developing countries. UW Biostatistics Working Paper Series. 2004, 195
Hughes JP, Haley DF, Golin CE, Adimora AA, Kuo I, Justman J, Soto-Torres L, Wang J, Hodder S . Regression to the mean and changes in risk behavior following study enrollment in a cohort of U.S. women at risk for HIV. 2015
Hughes JP, Richardson BA . Analysis of a randomized trial to prevent vertical transmission of HIV-1. JASA. 2000, 95: 1032-43
Hultin LE, Chow M, Jamieson BD, O'Gorman MRG, Menendez FA, Borowski L, Denny TN, and Margolick JB . Comparison of inter-laboratory variation in absolute T-cell counts by single-platform and optimized dual-platform methods. Cytometry Part B. 2010, 78: 194-200 PMCID: 3086643
Huppert JS, Hesse EA, Bernard MA, Xiao Y, Huang B, Gaydos CA, Kahn SA . Acceptability of self-testing for trichomoniasis increases with experience. Sex Transm Infect. 2011, 87: 494-500 PMCID: 3187610
Hussen SA, Stephenson R, Del Rio C, Wilton L, Wallace J, Wheeler D; HPTN 061 Protocol Team . HIV Testing Patterns among Black Men Who Have Sex with Men: A Qualitative Typology. PLoS One. 2013, 8: e75382 PMCID: 3777907
Incidence Assay Critical Path Working Group . More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med. 2011, 8: e1001045 PMCID: 3114871
Irvin R, Vallabhaneni S, Scott H, Williams JK, Wilton L, Li X, Buchbinder S; HPTN 061, Buchbinder S, HPTN 061 . Examining Levels of Risk Behaviors among Black Men Who Have Sex with Men (MSM) and the Association with HIV Acquisition. PLoS One. 2015, 10
Irvin R, Wilton L, Scott H, Beauchamp G, Wang L, Betancourt J, Lubensky M, Wallace J, Buchbinder S . A Study of Perceived Racial Discrimination in Black Men Who Have Sex with Men (MSM) and Its Association with Healthcare Utilization and HIV Testing. AIDS Behav. 2014, 18: 1272-8
Jackson B, Mmiro F, HIVNET 012 Study Team . HIVNET 012 and Petra (authors' reply). Lancet. 2004, 363: 244
Jackson JB, Barnett S, Piwowar-Manning E, Apuzzo L, Raines, C, Hendrix C, Hamzeh F, Gallant J . A Phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk. AIDS. 2003, 17: 547-53
Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, Mofenson LM, Mirochnick M, Mmiro F, Eshleman SH . Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS. 2000, 14: F111-5
Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F . Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003, 362: 859-68
Jackson JB, Parsons T, Musoke P, Nakabiito C, Donnell D, Fleming T, Mirochnick M, Mofenson L, Fowler MG, Mmiro F, Guay L . Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission. AIDS. 2006, 20: 217-22 PMID: 16511414
Jackson JB, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G, Donnell D, Ruan Y, Ma L, Metzger D, Shao Y . Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand. Hepat Res Treat. 2014, 2014: 296958
Jacob ST, Baeten JM, Hughes JP, Peinado J, Wang J, Sanchez J, Reid SE, Delany-Moretlwe S, Cowan F, Fuchs JD, Koblin B, Griffith S, Wald A, Celum C . A Post-Trial Assessment of Factors Influencing Study Drug
Adherence in a Randomized Biomedical HIV-1 Prevention Trial
. AIDS Behav. 2010, 15: 897-904 PMCID: 3076532
James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH . Antibody maturation and viral diversification in HIV-infected women. PLoS One. 2013, 8: e57350 PMCID: 3583828
James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel JM, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH . Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. Pediatr Infect Dis J. 2012, 31: e222-8 PMCID: 3473149
James MM, Wang L, Musoke P, Donnell D, Fogel J, Towler WI, Khaki L, Nakabiito C, Jackson JB, Eshleman SH . Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS One. 2011, 6: e18642 PMCID: 3077388
Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP . New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998, 280: 42-48
Jennings L, Pettifor A, Hamilton E, Ritchwood TD, Xavier Gomez-Olive F, MacPhail C, Hughes JP, Selin A, Kahn K, HPTN 068 Study Team . Economic Resources and HIV Preventive Behaviors Among School-Enrolled Young Women in Rural South Africa (HPTN 068). AIDS Behav.
Jennings L, Rompalo AM, Wang J, Hughes J, Adimora AA, Hodder S, Soto-Torres LE, Frew PM, Haley DF; HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), Haley DF, HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study . Prevalence and Correlates of Knowledge of Male Partner HIV Testing and Serostatus Among African-American Women Living in High Poverty, High HIV Prevalence Communities (HPTN 064). AIDS Behav. 2015, 19: 291-301
Joglekar N, Joshi S, Kakde M, Fang G, Cianciola M, Reynolds S, Mehendale S; HIV Prevention Trial Network 047 Protocol Team . Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India. AIDS Care. 2007, 19: 817-21 PMID: 17573603
John GC, Sheppard H, Mbori-Ngacha D, Nduati R, Maron D, Reiner M, Kreiss J . Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr. 2001, 26: 170-5
Jones D, Parkin N, Hudelson SE, Guay LA, Musoke P, Mmiro F, Jackson JB, Eshleman SH . Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine. AIDS Res Hum Retroviruses. 2005, 21: 319-24
Joshi S, Dutta S, Bell B, Profy A, Kuruc J, Fang G, Cianciola M, Maslankowski L, Soto-Torres L, Panchanadikar A, Mehendale S, Reynolds SJ . Documenting intermenstrual bleeding in a vaginal microbicide study: case reports and lessons learned. AIDS Res Hum Retroviruses. 2006, 22: 294-6
Justman J, Befus M, Hughes J, Wang J, Golin CE, Adimora AA, Kuo I, Haley DF, Del Rio C, El-Sadr WM, Rompalo A, Mannheimer S, Soto-Torres L, Hodder S . Sexual Behaviors of US Women at Risk of HIV Acquisition: A Longitudinal Analysis of Findings from HPTN 064. AIDS Behavior. 2015, 19: 1327-37
Justman J, Goldberg A, Reed J, Bock N, Njeuhmeli E, Goldzier Thomas A . Adult male circumcision: reflections on successes and challenges. J Acquir Immune Defic Syndr. 2013, 63: S140-3
K. Rivet Amico, Melissa Wallace, Linda-Gail Bekker, Surita Roux, Millicent Atujuna, Elaine Sebastian, Bonnie J. Dye, Vanessa Elharrar, Robert M. Grant . Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
Kafulafula G, Mwatha A, Chen YQ, Aboud S, Martinson F, Hoffman I, Fawzi W, Read JS, Valentine M, Mwinga K, Goldenberg R, Taha TE . Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa. Pediatrics. 2009, 124: e137-44 PMCID: 2764263
Kajeepeta S, MacPhail C, Selin A, Gómez-Olivé FX, Gottert A, Kahn K, Hughes JP, Pettifor A . Gender attitudes and associations with sexual risk behaviors and outcomes among young South African women (HPTN 068).
Kaleebu P, Njai HF, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Emel L, Musoke P, Fowler MG, Ou SS, Jackson JB, Guay L, Andrew P, Baglyos L, Cao H; HPTN 027 protocol team . Immunogenicity of ALVAC-HIV vCP1521 in Infants of
HIV-1–Infected Women in Uganda (HPTN 027): The First
Pediatric HIV Vaccine Trial in Africa
. J Acquir Immune Defic Syndr. 2014, 65: 268-77
Kapiga S, Kelly C, Weiss S, Daley T, Peterson L, Leburg C, Ramjee G . Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study. Sex Transm Dis. 2009, 36: 199-206 PMID:19265734
Kapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund SH . HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial. Sex Transm Dis. 2009, 36: 129-33 PMCID: 2889146
Karim QA, Baxter C, Karim SA . Topical microbicides--what's new?. J Acquir Immune Defic Syndr. 2013, 63: S144-9
Kashuba AD, Patterson KB, Dumond JB, Cohen MS . Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet. 2012, 379: 2409-11
Kawichai S, Celentano D, Srithanaviboonchai K, Wichajarn M, Pancharoen K, Chariyalertsak C, Visrutaratana S, Khumalo-Sakutukwa G, Sweat M, Chariyalertsak S; and The Project Accept Study Team . NIMH Project Accept (HPTN 043) HIV/AIDS Community Mobilization (CM) to Promote Mobile HIV Voluntary Counseling and Testing (MVCT) in Rural Communities in Northern Thailand: Modifications by Experience. AIDS Behav. 2012, 16: 1227-37 PMCID: 3355230
Kawichai S, Celentano DD, Chariyalertsak S, Visrutaratna S, Short O, Ruangyuttikarn C, Chariyalertsak C, Genberg B, Beyrer C . Community-based voluntary counseling and testing services in rural communities of Chiang Mai Province, Northern Thailand. AIDS Behav. 2007, 11: 770-7 PMID: 17503171
Keating SM, Bollinger RC, Quinn TC, Jackson JB, Carruth LM . Cross-clade T Lymphocyte Mediated Immunity to HIV-1: Implications for Vaccine Design and Immunodetection Assays. AIDS Res Hum Retroviruses. 2002, 18: 1067-79
Keating SM, Hanson D, Lebedeva M, Laeyendecker O, Ali-Napo NL, Owen SM, Stramer SL, Moore R, Norris PJ, Busch MP . Lower-sensitive and avidity modifications of the vitros anti-HIV1+2 assay for detection of recent HIV infections and incidence estimation. J Clin Microbiol. 2012, 50: 3968-76 PMCID: 3503010
Kevany S, Khumalo-Sakutukwa G, Murima O, Chingono A, Modiba P, Gray G, Van Rooyen H, Mrumbi K, Mbwambo J, Kawichai S, Chariyalertsak S, Chariyalertsak C, Paradza E, Mulawa M, Curran K, Fritz K, Morin SF . Health diplomacy the adaptation of global health interventions to local needs in sub-Saharan Africa and Thailand: evaluating findings from Project Accept (HPTN 043). BMC Public Health. 2012, 12: 459 PMCID: 3552975
Kevany S, Khumalo-Sakutukwa G, Singh B, Chingono A, Morin S, NIMH Project Accept Study Team . Global Health Diplomacy, Monitoring & Evaluation, and the Importance of Quality Assurance & Control: Findings from NIMH Project Accept (HPTN 043). PLoS One. 2016, 11: e0149335
Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S . Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital). S Afr Med J. 2009, 99: 320-5 PMID:19588792
Kevany S, Murima O, Singh B, Hlubinka D, Kulich M, Morin SF, Sweat M . Socio-economic status and health care utilization in rural Zimbabwe: findings from Project Accept (HPTN 043). J Public Health Africa. 2012, 3: 46-51 PMCID: 3436598
Kevany S, Sweat M, Singh B, Kulich M, Woelk G . Socio-economic status and health care utilization in rural Zimbabwe: Findings from Project Accept (HPTN 043). J of Public Health in Africa. 2012, 3: 46-51 (Not a PMC Journal)
Khumalo-Sakutukwa G, Morin SF, Fritz K, Charlebois ED, Van Rooyen H, Chingono A, Modilba P, Mrumbi K, Visrutaratna S, Singh B, Sweat M, Celentano DD, Coates TJ . Project Accept (HPTN 043): A Community-Based Intervention to Reduce HIV Incidence in Populations at Risk for HIV in Sub-Saharan Africa and Thailand. JAIDS. 2008, 49: 422-31 PMCID:2664736
Kilewo C, Natchu UCM, Young A, Donnell D, Brown E, Read JS, Sharma U, Chi BH, Goldenberg R, Hoffman I, Taha TE, Fawzi WW . Hypertension in Pregnancy among HIV-Infected Women in Sub-Saharan Africa: Prevalence and Infant Outcomes.. African Journal of Reproductive Health. 2009, 13: 25-36 PMID:20690271
Kilmarx PH, Paxton L, Van Damme L, Rees h, Ramjee G, Laga M, Mâsse B . Need for a true placebo for vaginal microbicide efficacy trials. Lancet. 2003, 361: 785-786
Kim HN, Wang J, Hughes J, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH, Khaki L, McMahon MA, Siliciano RF, Wald A, Celum C . Effect of Acyclovir on HIV 1 Set Point among Herpes Simplex Virus Type 2 Seropositive Persons during Early HIV 1 Infection. J Infect Dis. 2010, 202: 734-8 PMCID: 2964878
Kintu K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, Wang L, Fowler MG, Emel L, Ou SS, Baglyos L, Gurunathan S, Zwerski S, Jackson JB, Guay L . Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa. J Acquir Immune Defic Syn. 2013, 63: 1-8 PMCID: 3625520
Kirkpatrick AR, Patel EU, Celum CL, Moore RD, Blankson JN, Mehta SH, Kirk GD, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O . Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. AIDS Res Hum Retroviruses.
Klevytska AM, Mracna MR, Guay L, Becker-Pergola G, Furtado M, Zhang, L, Jackson JB, and Eshleman SH . Analysis of length variation in the V1-V2 region of env in non-subtype B HIV-1 from Uganda. AIDS Res Hum Retroviruses. 2002, 18: 791-6
Koblin BA, Andrasik M, Austin J . Preparing for the unexpected: the pivotal role of social and behavioral sciences in trials of biomedical HIV prevention interventions. J Acquir Immune Defic Syndr. 2013, 63: S183-6 PMCID: 3737568
Koblin BA, Chesney MA, Husnik MJ, Bozeman S, Celum CL, Buchbinder S, Mayer K, McKirnan D, Judson FN, Huang Y, Coates TJ . High-Risk Behaviors Among Men Who Have Sex With Men in 6 US Cities: Baseline Data From the EXPLORE Study. Am J Public Health. 2003, 93: 926-32
Koblin BA, Heagerty P, Sheon A, Buchbinder S, Celum C, Douglas JM, Gross M, Marmor M, Mayer K, Metzger D, Seage G . Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS. 1998, 12: 785-93
Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, Barresi PJ, Coates TJ, Chesney MA, Buchbinder S . Risk factors for HIV infection among men who have sex with men. AIDS. 2006, 20: 731-9 PMID: 16514304
Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L, Liu TY, Cummings V, Piwowar-Manning E, Fields SD, Griffith S, Elharrar V, Wheeler D; HPTN 061 Protocol Team . Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061. PLoS One. 2013, 8: e70413 PMCID: 3724810
Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O . Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS One. 2013, 8: e82772
Kozlov AP, Shaboltas AV, Toussova OV, Verevochkin SV, Masse BR, Perdue T, Beauchamp G, Sheldon W, Miller WC, Heimer R, Ryder RW, Hoffman IF . HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS. 2006, 20: 901-6 PMID: 16549975
Kuder M, Goheen MJ, Dize L, Barnes M, Gaydos CA . Evaluation of a new website design for iwantthekit for chlamydia, gonorrhea, and trichomonas screening. Sex Transmit Dis. 2015, 42: 243-5
Kumarasamy N, Flanigan TP, Mahajan AP, Carpenter CC, Mayer KH, Solomon S . Monitoring HIV treatment in the developing world. Lancet Infect Dis. 2002, 2: 656-7
Kumarasamy N, Mahajan AP, Flanigan TP, Hemalatha R, Mayer KH, Carpenter CCJ, Thyagarajan SP, Solomon S . Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr. 2002, 31: 378-83
Kumarasamy N, Solomon S, Chaguturu SK, Mahajan AP, Flanigan TP, Balakrishnan P, Mayer KH . The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS. 2003, 17: 2267-9
Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH . Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003, 36: 79-85
Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, Flanigan TP, Carpenter CC, Solomon S, Mayer KH . Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr. 2006, 41: 53-8 PMID: 16340473
Kumwenda N, Hoffman I, Chirenje M, Kelly C, Coletti A, Ristow A, Martinson F, Brown J, Chilongozi D, Richardson B, Rosenberg Z, Padian N, Taha T . HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis. 2006, 33: 646-51 PMID: 16773032
Kumwenda NI, Taha TE, Hoover DR, Markakis D, Liomba GN, Chiphangwi JD, Celentano DD . HIV-1 incidence among male workers at a sugar estate in rural Malawi. J Acquir Immune Defic Syndr. 2001, 27: 202-8
Kumwenda NI, Taha TE, Hoover DR, Markakis D, Liomba GN, Chiphangwi JD, Celentano DD . Three Surveys of HIV-1 Prevalence and Risk Factors Among Men Working at a Sugar Estate in Malawi. Sex Transm Dis. 2002, 29: 366-371
Kuo I, Golin CE, Wang J, Haley DF, Hughes J, Mannheimer S, Justman J, Rompalo A, Frew PM, Adimora AA, Soto-Torres L, Hodder S; HPTN 064 Study Team, Hodder S, HPTN 064 Study Team . Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States. Drug Alcohol Depend. 2014, Jun 1: 93-9
Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN . Combination HIV Prevention: Significance, Challenges, and Opportunities. Curr HIV/AIDS Rep. 2011, 8: 62-72 PMCID: 3036787
Kurth AE, Mayer K, Beauchamp G, McKinstry L, Farrior J, Buchacz K, Donnell D, Branson B, El-Sadr W; HPTN (065) TLC-Plus Study Team . Clinician practices and attitudes regarding early antiretroviral therapy in the United States. J Acquir Immune Defic Syndr. 2012, 61: e65-9 PMCID: 3957230
Lade JM, To EE, Hendrix CW, Bumpus NN . Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner. EBioMedicine. 2015, 2: 1145-52
Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH . HIV incidence determination in the United States: A multi-assay approach. J Infect Dis. 2013, 207: 232-9 PMCID: 3532826
Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH; for the Partners in Prevention HSV/HIV Transmission Study Team . Specificity of four laboratory approaches for cross-sectional HIV incidence determination: Analysis of samples from adults with known nonrecent HIV infection from five African countries. AIDS Res Hum Retroviruses. 2012, 28: 1177-83 PMCID: 3448109
Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH . Multicenter AIDS Cohort Study (MACS). Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses. 2012, 28: 816-22 PMCID: 3399553
Laeyendecker O, Church JD, Oliver AE, Mwatha A, Owen SM, Donnell D, Brookmeyer R, Musoke P, Jackson JB, Guay L, Nakabiito C, Quinn TC, Eshleman SH . Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. PLoS One. 2010, 5: e 13259 PMCID: 2952593
Laeyendecker O, Latimore A, Eshleman SH, Summerton J, Oliver AE, Gamiel J, Dobbs T, Mei J, Murphy G, Parry JV, Owen SM, Quinn TC . The effect of sample handling on cross sectional HIV incidence testing results. PLoS One. 2011, 6: e25899 PMCID: 3202521
Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Swanson P, Hackett J Jr, et al . Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). PLoS One. 2013, 8: e68349
Laeyendecker O, Redd AD, Nason M, Longosz AF, Karim QA, Naranbhai V, Garrett N, Eshleman SH, Abdool Karim SS, Quinn TC . Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. J Infect Dis. 2015, 212: 754-9
Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlogetswe KS, Kraus CK, Shahan J, Kelen GD, Quinn TC . The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins hospital emergency department. J Acquir Immune Defic Syndr. 2008, 48: 211-215 PMCID: 2738975
Lai S, Chen J, Celentano D, Page JB, Lai H, Yang J, Liu W, McCoy CB, Yu XF . Adoption of injection practices in heroin users in Guangxi Province, China. J Psychoactive Drugs. 2000, 32: 285-92
Latkin C, Donnell D, Celentano DD, Aramrattna A, Liu TY, Vongchak T, Wiboonnatakul K, Davis-Vogel A, Metzger D . Relationships between social norms, social network characteristics, and HIV risk behaviors in Thailand and the United States. Health Psychol. 2009, 28: 323-9 PMCID: 2799116
Latkin C1, Donnell D, Liu TY, Davey-Rothwell M, Celentano D, Metzger D, Latkin C . The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013, 108: 934-43
Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, Quan VM, Gandham S, Vongchak T, Perdue T, Celentano DD . The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soci Sci Med. 2009, 68: 740-8 PMCID:2724962
Lee EJ, Kantor R, Zijenah L, Sheldon W, Emel L, Mateta P, Johnston E, Wells J, Shetty AK, Coovadia H, Maldonado Y, Adeniyi Jones S, Mofenson L, Contag CH, Bassett M, Katzenstein DA . Breast-milk shedding of drug-resistant HIV-1 Subtype C in women exposed to single-dose nevirapine. J Infect Dis. 2005, 192: 1260-4
Lidström J, Li Q, Hoover DR, Kafulafula G, Mofenson LM, Fowler MG, Thigpen MC, Kumwenda N, Taha TE, Eshleman SH . Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero. AIDS. 2010, 24: 381-6 PMCID: 3063063
Liu W, Chen J, Rodolph M, Beauchamp G, Masse B, Wang S, Li R, Ruan Y, Zhou F, Leung MK, Lai S, Shao Y, Jackson JB . HIV prevalence among injection drug users in rural Guangxi China. Addiction. 2006, 101: 1493-8 PMID: 16968351
Lole K, Bollinger RC, Paranjape R, Gadkari D, Kulkarni S, Novak N, Ingersoll R, Sheppard H, Rau S . Full-length human immunodeficiency virus type 1 genomes from subtype c-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999, 73: 152-160
London AJ, Borasky DA Jr, Bhan A for the Ethics Working Group of the HIV Prevention Trials Network . Improving Ethical Review of Research Involving Incentives for Health Promotion. PLoS Med. 2012, 9: e1001193 PMCID: 3313933
London AJ, Borasky DA Jr, Bhan A; Ethics Working Group of the HIV Prevention Trials Network . Improving ethical review of research involving incentives for health promotion. PLoS Med. 2012, 9: e1001193
Longosz AF, Mehta S, Kirk GD, Margolick JB, Brown J, Quinn TC, Eshleman SH, Laeyendecker O . Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS. 2014, 28: 1227-32 PMCID: 4102639
Longosz AF, Morrison CS, Chen P-L, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O, Chen PL . Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay. J Acquir Immune Defic Syndr. 2014, 65: 390-6
Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O . Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. AIDS Res Hum Retroviruses. 2015, 31: 421-7
Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O . Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda. AIDS Res Hum Retroviruses. 2014, 30: 339-44 PMCID: 3976571
Lu Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L, Hendrix CW . Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations. Antimicrob Agents Chemother. 2012, 56: 2777-9 PMCID: 3346629
Lu, Y, Hendrix CW, Bumpus NN . Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc. Drug Metabol Dispos. 2012, 40: 2221-30 PMCID: 3500548
Lucas GM, Beauchamp G, Aramrattana A, Shao Y, Liu W, Fu L, Jackson JB, Celentano DD, Richardson P, Metzger D; for the HPTN 058 study group . Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058. Int J Drug Policy. 2012, 23: 162-5 PMCID: 3236277
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celantano D, Metzger D, Jackson JB, Burns D, HPTN 058 study group . Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand. Drug Alcohol Depend. 2014, Sep 1: 139-45 PMCID: 4127183
Lynch KL, Breaud AR, Vandenberghe H, Wu AH, Clarke W . Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening. Clin Chim Acta. 2010, 411: 1474-81 PMCID: 2974548
Machekano R, McFarland W, Hudes E, Bassett MT, Mbizvo MT, Katzenstein D . Correlates of HIV test results seeking and utilization of partner counseling services in a corhort of male factory workers in Zimbabwe. AIDS Behav. 2000, 4: 63-70
Machekano R, McFarland W, Mbizvo MT, Bassett MT, Katzenstein D, Latif AS . Impact of HIV counselling and testing on HIV seroconversion and reported STD incidence among male factory workers in Harare, Zimbabwe. Central Af J Med. 1998, 44: 98-102
Machekano RN, Bassett MT, Zhou PS, Mbizvo MT, Latif AS, Katzenstein DA . Report of sexually transmitted diseases by HIV infected men during follow up: time to target the infected?. Sex Transm Infect. 2000, 76: 188-92
MacQueen K, Alleman P . International Perspectives on the Collection, Storage, and Testing of Human Biospecimens in HIV Research. IRB: Ethics and Human Research. 2008, 30: 9-14 PMID:18767319
MacQueen KM, Abdool Karim Q, Sugarman J . Ethics guidance for HIV prevention trials. BMJ. 2003, 327: 340
Macqueen KM, McLoughlin K, Alleman P, Burke HM, Mack N . Partnering for Care in HIV Prevention Trials. J Empir Res Hum Res Ethics. 2008, 3: 5-18 PMID:19385753
Macqueen KM, Namey E, Chilongozi DA, Mtweve SP, Mlingo M, Morar N, Reid C, Ristow A, Sahay S, HPTN 035 Standard of Care Assessment Team . Community perspectives on care options for HIV prevention trial participants. AIDS Care. 2007, 19: 554-60 PMID:17453597
MacQueen KM, Sugarman J . Back to the Rough Ground: Working in International HIV Prevention Research as Ethical Debates Continue. IRB: Ethics and Human Research. 2003, 25: 11-13
Magidson JF, Li X, Mimiaga MJ, Moore AT, Srithanaviboonchai K, Friedman RK, Limbada M, Hughes JP, Cummings V, Gaydos CA, Elharrar V, Celentano D, Mayer KH, Safren SA . Antiretroviral Medication Adherence and Amplified HIV Transmission Risk Among Sexually Active HIV-Infected Individuals in Three Diverse International Settings. AIDS and Behavior. 2016
Magnus M, Franks J, Griffith S, Arnold MP, Goodman K, Wheeler DP; for the HPTN 061 Study Group, Wheeler DP, HPTN 061 Study Group . Engaging, Recruiting, and Retaining Black Men Who Have Sex With Men in Research Studies: Don't Underestimate the Importance of Staffing-Lessons Learned From HPTN 061, the BROTHERS Study. J Public Health Manag Pract. 2014, 20: E1-9
Mahajan AP, Hogan JW, Snyder B, Kumarasamy N, Mehta K, Solomon S, Carpenter CC, Mayer KH, Flanigan TP . Changes in Total Lymphocyte Count as a Surrogate for Changes in CD4 Count Following Initiation of HAART: Implications for Monitoring in Resource-Limited Settings. J Acquir Immune Defic Syndr. 2004, 36: 567-575
Mahlokozera T, Kang HH, Goonetilleke N, Stacey AR, Lovingood RV, Denny TN, Kalilani L, Bunn JE, Meshnick SR, Borrow P, Letvin NL, Permar SR . The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk. PLoS One. 2011, 6: e23735 PMCID:3160326
Maman S, Abler L, Parker L, Lane T, Chirowodza A, Ntogwisangu J, Srirak N, Modiba P, Murima O, Fritz K . A comparison of HIV stigma and discrimination in five international sites: the influence of care and treatment resources in high prevalence settings. Soc Sci Med. 2009, 68: 2271-8 PMCID: 2696587
Maman S, Lane T, Ntogwisangu J, Motholo T, Sikotoyi S, Visrutaratna S, Fritz K, Chitumba A . Using participatory mapping to inform the research and intervention design of a multi-site community-randomized trial of community-based HIV counseling and testing. Journal Field Methods. 2009, 21: 368-387 (Journal Field Methods is not a PMC Journal)
Maman S, van Rooyen H, Stankard P, Chingono A, Muravha T, Ntogwisangu J, Phakathi Z, Srirak N, Morin S; NIMH Project Accept (HPTN 043) study team . NIMH Project Accept (HPTN 043): results from in-depth interviews with a longitudinal cohort of community members. PLoS One. 2014, 9: e87091 PMCID: 3906114
Mannheimer S, Wang L, Wilton L, Tieu HV, Del Rio C, Buchbinder S, Fields S, Glick S, Conor MB, Cummings V, Eshleman SH, Koblin B, Mayer KH . Infrequent HIV Testing and Late HIV Diagnosis Are Common Among US Black Men Who Have Sex with Men (BMSM). J Acquir Immune Defic Syndr. 2014, 67: 438-45
Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage G . Homozygous and Heterozygous CCR5-32 Genotypes are Associated with Resistence to HIV infection. J Acquir Immune Defic Syndr. 2001, 27: 472-81
Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB . Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999, 354: 803-9
Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB . The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa. Ann N Y Acad Sci. 2000, 918: 53-6
Marzinke M, Breaud A, Parsons TL, Cohen MS, Piwowar-Manning E, Eshleman SH, Clarke W . The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood. Clin Chim Acta. 2014, 10: 157-68
Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, Wheeler DP, Koblin BA, Eshleman SH, Fogel JM . Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis. 2014, 58: 117-20
Masek BJ, Arora N, Quinn N, Aumakhan B, Holden J, Hardick A, Agreda P, Barnes M, Gaydos CA . Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J Clin Microbiol. 2009, 47: 1663-7 PMCID: 2691063
Masemola A, Mashishi T, Khoury G, Mohube P, Mokgotho P, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM; HIVNET 028 Study Team . Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol. 2004, 78: 3233-43
Masemola AM, Mashishi TN, Khoury G, Bredell H, Paximadis M, Mathebula T, Barkhan D, Puren A, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM; HIVNET 028 Study Team . Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol. 2004, 173: 4607-17
Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, Laeyendecker O, Oluoch T, Garcia-Calleja JM . Estimating HIV incidence in populations Using tests for recent Infection: Issues, challenges and the way forward. J HIV/AIDS Surv & Epidemiol. 2010, 2: 1-14 PMCID: 3130510
Mauck C, Rosenberg Z, Van Damme L . Recommendations for the clinical development of topical microbicides: an update. AIDS. 2001, 15: 857-68
Mayer K, Karim S, Kelly C, Maslankowski L, Rees H, Profy A, Day J, Welch J, Rosenberg Z . Safety and tolerability of vaginal PRO2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS. 2003, 17: 321-9
Mayer K, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, Bentley M, Chesney M, Rosenberg Z . Safety and tolerability of Buffergel, a novel vaginal microbicide, in women in the United States. Clin Infect Dis. 2001, 32: 476-82
Mayer KH, Kwong J, Singall R, Boswell S . Non-occupational post-exposure prophylaxis: Clinical issues and public health questions. Medicine and Health/Rhode Island. 2000, 83: 210-3
Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Masse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L; HPTN 050 Protocol Team . Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006, 20: 543-51 PMID: 16470118
Mayer KH, Pizer HF . HIV Prevention: A Comprehensive Approach. London Academic Press. 2008, ISBN: 0123742358
Mayer KH, Venkatesh KK . Antiretroviral therapy as HIV prevention: status and prospects. Am J Public Health. 2010, 100: 1867-76 PMCID: 2936983
Mayer KH, Wang L, Koblin B, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson CC, Piwowar-Manning E, Gaydos C, Eshleman SH, Clarke W, Liu TY, Mao C, Griffith S, Wheeler D; HPTN061 Protocol Team, Wheeler D, HPTN 061 Protocol Team . Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities. PLoS One. 2014, 9: e87298 PMCID: 3909083
Mayer KH, Wheeler DP, Bekker LG, Grinsztejn B, Remien RH, Sandfort TG, Beyrer C . Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men. J Acquir Immune Defic Syndr. 2013, 63: S161-7 PMCID: 3740716
McConnell MS, Stringer JS, Kourtis AP, Weidle PJ, and Eshleman SH . Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?. Am J Obstet Gynecol. 2007, 197: S56-S63 PMID: 17825651
McFarland W, Gwanzura L, Bassett MT, Machekano R, Latif AS, Le C, Parsonnet J, Burke RL, Katzenstein D . Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis. 1999, 180: 1459-65
McFarland W, Mvere D, Shamu R, Katzenstein D . Risk factors for HIV infection among first-time blood donors in Zimbabwe. Transfusion. 1998, 38: 279-84
McGowan I, Elliott J, Cortina G, Tanner K, Siboliban C, Adler A, Cho D, Boscardin WJ, Soto-Torres L, Anton PA . Characterization of baseline intestinal mucosal indices of injury and inflammation in men for use in rectal microbicide trials (HIV Prevention Trials Network-056). J Acquir Immune Defic Syndr. 2007, 46: 417-25 PMID: 17891044
Meany DL, Clarke W . Opiate DAU screening using dried urine specimens. Clin Chim Acta. 2009, 401: 188-189 PMCID:2634819
Mehendale SM, Ghate MV, Kishore Kumar B, Sahay S, Gamble TR, Godbole SV, Thakar MR, Kulkarni SS, Gupta A, Gangakhedkar RR, Divekar AD, Risbud AR, Paranjape RS, Bollinger RC . Low HIV-1 Incidence among Married Serodiscordant Couples in Pune, India. J Acquir Immune Defic Syndr. 2006, 41: 371-373 PMID: 16540940
Mehendale SM, Shepherd ME, Brookmeyer RS, Semba RD, Divekar AD, Gangakhedkar RR, Joshi S, Risbud AR, Paranjape RS, Gadkari DA, Bollinger RC . Low carotenoid concentration and the risk of HIV seroconversion in Pune, India. J Acquir Immune Defic Syndr. 2001, 26: 352-9
Mehta S, Manji KP, Young AM, Brown ER, Chasela C, Taha TE, Read JS, Goldenberg RL, Fawzi WW . Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women. Am J Clin Nutr. 2008, 87: 1639-49 PMCID:2474657
Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN; HPTN 058 Protocol Team, Burns DN, HPTN 058 Protocol Team . Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine-Naloxone: HIV Prevention Trials Network 058. JAIDS. 2015, 68: 554-61
Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, Gross M, Sheon A, Miller H, Cooley P, Seage GR 3rd . Randomized controlled trial of audio computer-assisted self- interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000, 152: 99-106
Mimiaga MJ, Noonan E, Donnell D, Safren SA, Koenen KC, Gortmaker S, O'Cleirigh C, Chesney MA, Coates TJ, Koblin BA, Mayer KH . Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE Study. J Acquir Immune Defic Syndr. 2009, 51: 340-8 PMCID: 3292283
Mimiaga MJ, Safren SA, Benet DJ, Manseau MW, DeSousa N, Mayer KH . MSM in HIV-prevention trials are sexual partners with each other: An ancillary study to the EXPLORE intervention. AIDS Behav. 2006, 10: 27-34 PMID: 16331532
Mindry D, Maman S, Chirowodza A, Muravha T, van Rooyen H, Coates T . Looking to the future: South African men and women negotiating HIV risk and relationship intimacy. Cult Health Sex. 2011, 13: 589-602 PMCID: 3071520
Miotti, Taha, Kumwenda, Broadhead, Mtimavalye, Hoeven, Chiphangwi, Liomba, Biggar, Miotti PG, Taha TE, Kumwenda NI, Broadhead R, Mtimavalye LA, Van der Hoeven L, Chiphangwi JD, Liomba G, Biggar RJ . HIV transmission from breastfeeding: a study from Malawi. JAMA. 1999, 282: 744-9
Mirochnick M, Nielsen-Saines K, Pilotto JH, Pinto J, Jiménez E, Veloso VG, Parsons T, Watts DH, Moye J, Mofenson LM, Camarca M, Bryson Y; NICHD/HPTN 040/PACTG 1043 Protocol Team . Nevirapine concentrations in newborns receiving an extended prophylactic regimen. J Acquir Immune Defic Syndr. 2008, 47: 334-7 PMID:18398973
Mirochnick M, Nielsen-Saines K, Pilotto JH, Pinto J, Veloso VG, Rossi S, Moye J, Bryson Y, Mofenson L, Camarca M, Watts DH; NICHD HPTN 040/PACTG 1043 Protocol Team . Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life. Pediatr Infect Dis J. 2011, 30: 769-72 PMCID: 3158246
Mirochnick M, Taha T, Kreitchmann R, Nielsen-Saines K, Kumwenda N, Joao E, Pinto J, Santos B, Parsons T, Kearney B, Emel L, Herron C, Richardson P, Hudelson SE, Eshleman SH, George K, Fowler MG, Sato P, Mofenson L; HPTN 057 Protocol Team . Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life. J Acquir Immune Defic Syndr. 2014, 65: 33-41
Mitchla Z, Sharland M . Current treatment options to prevent perinatal transmission of HIV. Expert Opin Pharmacother. 2000, 1: 239-48
Mmiro FA, Aizire J, Mwatha AK, Eshleman SH, Donnell D, Fowler MG, Nakabiito C, Musoke P, Jackson JB, Guay LA . Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda. J Acquir Immune Defic Syndr. 2009, 52: 32-9 PMCID: 2767188
Montgomery BE, Rompalo A, Hughes J, Wang J, Haley D, Soto-Torres L, Chege W, Justman J, Kuo I, Golin C, Frew P, Mannheimer S, Hodder S . Violence Against Women in Selected Areas of the United States. Am J Public Health. 2015, 105: 2156-66
Moon MW, Khumalo-Sakutukwa GN, Heiman JE, Mbizvo MT, Padian NS . Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say. J Transcult Nurs. 2002, 13: 19-23
Morin SF, Khumalo-Sakutukwa G, Charlebois ED, Routh J, Fritz K, Lane T, Vaki T, Fiamma A, Coates TJ . Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe. JAIDS. 2006, 41: 218-24 PMID: 16394855
Morin SF, Maiorana A, Koester KA, Sheon NM, Richards A . Community Consultation in HIV Prevention Research: A Study of Community Advisory Boards at 6 Research Sites. J Acquir Immune Defic Syndr. 2003, 33: 513-20
Morin SF, Morfit S, Maiorana A, Aramrattana A, Goicochea P, Mutsambi JM, Robbins JL, Richards TA . Building community partnerships: case studies of Community Advisory Boards at research sites in Peru, Zimbabwe, and Thailand. Clin Trials. 2008, 5: 147-56 PMID:18375653
Morris SR, Klausner JD, Buchbinder SP, Wheeler SL, Koblin B, Coates T, Chesney M, Colfax GN . Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis. 2006, 43: 1284-9 PMID: 17051493
Morrow K, Rosen R, Richter L, Emans A, Forbes A, Day J, Morar N, Maslankowski L, Profy AT, Kelly C, Abdool Karim SS, Mayer KH . The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. J Womens Health. 2003, 12: 655-66
Mracna M, Becker-Pergola G, Dileanis J, Guay LA, Cunningham S, Jackson JB, and Eshleman SH . Performance of the Applied Biosystems ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Non-Subtype B HIV-1 from Uganda. J Clin Microbiol. 2001, 39: 4323-7
Msamanga GI, Taha TE, Young AM, Brown ER, Hoffman IF, Read JS, Mudenda V, Goldenberg RL, Sharma U, Sinkala M, Fawzi WW . Placental malaria and mother-to-child transmission of human immunodeficiency virus-1. Am J Trop Med Hyg. 2009, 80: 508-15, No PMCID http://www.ajtmh.org/content/80/4/508.long
Mugerwa R, Kaleebu P, Mugyenyi P, Katongole-Mbidde E, Hom D, George K, Kebba A, Johnson JL, Schmidt C, Sempala SD, Kityo C, Byaruhanga R, Mugisha E, Flores J, Sheppard CH, Cao H, Othieno C, Allen M, Salata RA, Ellner J for the HIVNET 007 Protocol Team . First trial of the HIV-1 vaccine in Africa: Ugandan experience. BMJ. 2002, 324: 226-9
Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB . A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS. 1999, 13: 479-86
Musoke PM, Young AM, Owor MA, Lubega IR, Brown ER, Mmiro FA, Mofenson LM, Jackson JB, Fowler MG, Guay LA . Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children. J Acquir Immune Defic Syndr. 2008, 49: 171-8. PMCID:2721476
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL . Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol. BMC Pedatr. 2009, 7: 49 PMCID: 2746190
Myron S. Cohen, Lawrence Corey, Cohen MS, Corey L . Broadly neutralizing antibodies to prevent HIV-1. Science. 2017, 358: 46-47
Naranbhai V, Moodley D, Chipato T, Stranix-Chibanda L, Nakabaiito C, Kamateeka M, Musoke P, Manji K, George K, Emel LM, Richardson P, Andrew P, Fowler M, Fletcher H, McShane H, Coovadia HM, Hill AV; HPTN 046 Protocol Team . The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women.. Journal of Acquired Immune Deficiency Syndromes. 2014, 67: 573-5
Ndovi TT, Cao YJ, Fuchs E, Fletcher CV, Guidos A, Hendrix CW . Food affects Zidovudine concentration independent of effects on gastrointestinal absorption. J Clin Pharmacol. 2007, 47: 1366-73
Ndovi TT, Choi L, Caffo B, Parsons T, Baker S, Zhao M, Rohde C, Hendrix CW . Quantitative assessment of seminal vesicle and prostate drug concentrations by use of a noninvasive method. Clin Pharmacol Ther. 2006, 80: 146-58 PMID: 16890576
Neal JD, Tobian AA, Laeyendecker O, Ngo TD, Redd AD, Reynolds SJ, Ashley Morrow R, Manucci JL, Serwadda D, Gray RH, Quinn TC . Performance of the Euroline Western blot assay in the detection of herpes simplex virus type 2 antibody in Uganda, China and the USA. Intl J STD and AIDS. 2011, 22: 342-344 PMCID: 3198953
Nelson LE, Wilton L, Moineddin R, Zhang N, Siddiqi A, Sa T, Harawa N, Regan R, Dyer TP, Watson CC, Koblin B, Del Rio C, Buchbinder S, Wheeler DP, Mayer KH; HPTN 061 Study Team, Mayer KH, HPTN 061 Study Team . Economic, Legal, and Social Hardships Associated with HIV Risk among Black Men who have Sex with Men in Six US Cities. J Urban Health. 2016, 93: 170-88
Nelson LE, Wilton L, Zhang N, Regan R, Thach CT, Dyer TV, Kushwaha S, Sanders RE 2nd, Ndoye O, Mayer KH, HPTN 061 Study Team . Childhood Exposure to Religions With High Prevalence of Members Who Discourage Homosexuality Is Associated With Adult HIV Risk Behaviors and HIV Infection in Black Men Who Have Sex With Men. Am J Mens Health.
Ng OT, Laeyendecker O, Redd AD, Munshaw S, Grabowski MK, Pacquet AC, Evans MC, Haddad M, Huang W, Robb ML, Reynolds S, Gray RH, Wawer MJ, Serwadda D, Eshleman SH, Quinn TC . HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression. J Infect Dis. 2014, 209: 66-73
Ngo TD, Laeyendecker O, Morrow RA, Lai S, Quinn TC . Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China. Clin Vaccine Immunol. 2008, 15: 1301-3 PMCID: 2519307
Nguyen NL, Powers KA, Hughes JP, MacPhail CL, Piwowar-Manning E, Patel EU, Gomez-Olive FX, Kahn K, Pettifor AE . Sexual Partnership Patterns Among South African Adolescent Girls Enrolled in STI Preventions Trial Network 068: Measurement Challenges and Implications for HIV/STI Transmission. Sex Transm Dis. 2015, 42: 612-8
Ojikutu BO, Pathak S, Srithanaviboonchai K, Limbada M, Friedman R, Li S, Mimiaga MJ, Mayer KH, Safren SA, HPTN 063 Team . Community Cultural Norms, Stigma and Disclosure to Sexual Partners among Women Living with HIV in Thailand, Brazil and Zambia (HPTN 063). PLoS One. 2016, 11: e0153600
Onyango-Makumbi C, Bagenda D, Mwatha A, Omer SB, Musoke P, Mmiro F, Zwerski SL, Kateera BA, Musisi M, Fowler MG, Jackson JB, Guay LA . Early Weaning of HIV-Exposed Uninfected Infants and Risk of Serious Gastroenteritis: Findings from Two Perinatal HIV Prevention Trials in Kampala, Uganda. J Acquir Immune Defic Syndr. 2010, 53: 20-27 PMCID: 2888913
Paranjape RS, Gadkari DA, Lubaki M, Quinn TC, Bollinger RC . Cross-reactive HIV-1 Specific CTL in Recent Seroconverters from Pune, India. IJMR. 1998, 108: 35-41
Patel EU, Cox AL, Mehta SH, Boon D, Mullis CE, Astemborski J, Osburn WO, Quinn J, Redd AD, Kirk GD, Thomas DL, Quinn TC, Laeyendecker O . Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection. J Infect Dis.
Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O . Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment. BMC Infect Dis. 2015, 15: 398
Pauk J, Huang M, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L . Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000, 343: 1369-78
Pechansky F, von Diemen L, Kessler F, Hirakata V, Metzger D, Woody GE . Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of Porto Alegre, Brazil. J Urban Health. 2003, 80: 115-25
Pequegnat W, Fishbein M, Celentano D, Ehrhardt A, Garnett G, Holtgrave D, Jaccard J, Schachter J, Zenilman J . NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sex Transm Dis. 2000, 27: 127-32
Pettifor A, Bekker L-G . Adolescent enrollment in HIV prevention trials. Lancet. 2012, 380: 646
Pettifor A, Bekker LG, Hosek S, DiClemente R, Rosenberg M, Bull SS, Allison S, Delany-Moretlwe S, Kapogiannis BG, Cowan F; HIV Prevention Trials Network (HPTN) Adolescent Scientific Committee . Preventing HIV among young people: research priorities for the future. J Acquir Immune Defic Syndr. 2013, 63: S155-60 PMCID: 3746811
Pettifor A, Corneli A, Kamanga G, McKenna K, Rosenberg NE, et al., Yu X, Ou SS, Massa C, Wiyo P, Lynn D, Tharaldson J, Golin C, Hoffman I, HPTN 062 Study Protocol Team . HPTN 062: A Pilot Randomized Controlled Trial Exploring the Effect of a Motivational-Interviewing Intervention on Sexual Behavior among Individuals with Acute HIV Infection in Lilongwe, Malawi. PLoS One. 2015, 10: e0124452
Pettifor A, MacPhail C, Selin A, Gomez-Olive FX, Rosenberg M, Wagner RG, Mabuza W, Hughes JP, Suchindran C, Piwowar-Manning E, Wang J, Twine R, Daniel T, Andrew P, Laeyendecker O, Agyei Y, Tollman S, Kahn K, HPTN 068 Protocol Team . HPTN 068: A Randomized Control Trial of a Conditional Cash Transfer to Reduce HIV Infection in Young Women in South Africa-Study Design and Baseline Results.. AIDS Behav. 2016, 20: 1683-82
Pettifor A, Wang J, Selin A, Hughes J, Gómez-Olivé X, Wagner R, MacPhail C, Kahn K, HPTN 068 Study Team . The impact of a cash transfer on young South African women's on mental health: HPTN 068.
Phakathi Z, Van Rooyen H, Fritz K, Richter L . The influence of antiretroviral treatment on willingness to test: a qualitative study in rural KwaZulu-Natal, South Africa. African Journal of AIDS Research. 2011, 10: 173-80
Ping LH, Jabara CB, Rodrigo AG, Hudelson SE, Piwowar-Manning E, Wang L, Eshleman SH, Cohen MS, Swanstrom R . HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study. PLoS One. 2013, 8: e71557
Piwowar-Manning E, Fiamma A, Laeyendecker O, Kulich M, Donnell D, Szekeres G, Robins-Morris L, Mullis CE, Vallari A, Hackett J Jr, Mastro TD, Gray G, Richter L, Alexandre MW, Chariyalertsak S, Chingono A, Sweat M, Coates T, Eshleman SH . HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043). BMC Infect Dis. 2011, 11: 251 PMCID: 3198953
Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke M, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Jr., Mannheimer S, del Rio C, Kuo I, Harawa NT, Koblin BA, Moore R, Blankson JN, Eshleman SH . Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. HIV Clin Trials. 2014, 15: 62-8
Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH . Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa. J Clin Virol. 2015, 62: 75-9
Piwowar-Manning E, Lugalia L, Kafufu B, Jackson JB . Comparison of results obtained with Amplicor HIV-1 DNA PCR test version 1.5 using 100 versus 500 microliters of whole blood. J Clin Microbiol. 2008, 46: 1104-5 PMCID: 2268375
Piwowar-Manning EM, Tustin NB, Sikateyo P, Kamwendo D, Chipungu C, Maharaj R, Mushanyu J, Richardson BA, Hillier S and Jackson JB . Validation of rapid HIV antibody tests in 5 African Countries. J Int Assoc Physicians in AIDS Care. J Int Assoc Physicians AIDS Care. 2010, 9: 170-2 PMCID: 2989535
Potter D, Goldenberg RL, Chao A, Sinkala M, Degroot A, Stringer JS, Bulterys M, Vermund SH . Do targeted HIV programs improve overall care for pregnant women?: Antenatal syphilis management in Zambia before and after implementation of prevention of mother-to-child HIV transmission programs. J Acquir Immune Defic Syndr. 2008, 47: 79-85 PMCID: 2745056
Potter D, Goldenberg RL, Read JS, Wang J, Hoffman IF, Saathoff E, Kafulafula G, Aboud S, Martinson FE, Dahab M, Vermund SH . Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia. Sex Transm Dis. 2006, 33: 604-9 PMCID: 2743105
Pruenglampoo B, Ruangyuttikarn C . Thai clinical research coordinator's journey in HIV/AIDS research. Research Practitioner. 2006, 7: 217-18
Rademeyer C, Moore PL, Taylor N, Martin DP, Choge IA, Gray ES, Sheppard HW, Gray C, Morris L, Williamson C; HIVNET 028 study team . Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies. Virology. 2007, 368: 172-81 PMID:17632196
Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, Masse B; the HPTN 055 Study Team . The Value of Site Preparedness Studies for Future Implementation of Phase 2/IIb/III HIV Prevention Trials: Experience From the HPTN 055 Study. JAIDS. 2008, 47: 93-100.
Ranganathan, M, Heise, L, Pettifor, A, Silverwood, RJ, Selin, A, MacPhail, C, Delany-Moretlwe, S, Kahn, K, Gomez-Olive, FX, Hughes, JP, Piwowar-Manning, E, Laeyendecker, O, Watts, C . Transactional sex among young women in rural South Africa: prevalence, mediators and association with HIV infection. 2016
Ray S, Latif A, Machekano R, Katzenstein DA . Sexual behavior and risk assessment among urban male factory workers in Zimbabwe. Soc Sci Med. 1998, 47: 1431-43
Read JS, Mwatha A, Richardson B, Valentine M, Emel L, Manji K, Hoffman I, Sharma U, Goldenberg RL, Taha TE . Primary HIV-1 infection among infants in sub-Saharan Africa: HPTN 024. JAIDS. 2009, 51: 317-22 PMCID: 2753468
Redd AD, Dabitao D, Bream JH, Charvat B, Laeyendecker O, Kiwanuka N, Lutalo T, Kigozi G, Tobian AA, Gamiel J, Neal JD, Oliver AE, Margolick JB, Sewankambo N, Reynolds SJ, Wawer MJ, Serwadda D, Gray RH, Quinn TC . Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci USA. 2009, 106: 6718-23 PMCID: 2667149
Redd AD, Laeyendecker O, Kong X, Kiwanuka N, Lutalo T, Huang W, Gray RH, Wawer MJ, Serwadda D, Eshleman, SH, Quinn TC; Rakai Health Sciences Program . Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression. AIDS Res Hum Retroviruses. 2012, 28: 289-94 PMCID: 3292754
Redd AD, Wendel SK, Longosz AF, Fogel JM, Dadabhai S, Kumwenda N, Sun J, Walker MP, Bruno D, Martens C, Eshleman SH, Porcella SF, Quinn TC, Taha TE . Evaluation of postpartum HIV superinfection and mother-to-child transmission. AIDS. 2015, 29: 1567-73
Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A, Celum C . Pregnancy, Contraceptive Use, and HIV Acquisition in HPTN 039: Relevance for HIV Prevention Trials Among African Women. J Acquir Immune Defic Syndr. 2009, 53: 606-13 PMCID: 2845724
Reller ME, Clemens EG, Schachterle SE, Mtove GA, Sullivan DJ, Dumler JS . Multiplex 5' nuclease-quantitative PCR for diagnosis of relapsing fever in a large Tanzanian cohort. J Clin Microbiol. 2011, 49: 3245-3249 PMCID: 3165610
Rennie S, Sugarman J . Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach. J Med Ethics. 2010, 36: 810-15 PMCID: 3129851
Reynolds SJ, Laeyendecker O, Nakigozi G, Gallant JE, Huang W, Hudelson SE, Quinn TC, Newell K, Serwadda D, Gray RH, Wawer MJ, Eshleman SH . Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda. AIDS Res Hum Retroviruses. 2012, 28: 1739-44 PMCID: 3505045
Richardson BA, Kelly C, Ramjee G, Fleming T, Makanani B, Roberts S, Musara P, Mkandawire N, Moench T, Coletti A, Soto-Torres L, Karim SA; HPTN 035 Study Team . Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035. J Acquir Immune Defic Syndr. 2013, 69: 120-5 PMCID: 3625489
Richardson BA, Lavreys L, Martin HL Jr, Stevens CE, Ngugi E, Mandaliya K, Bwayo J, Ndinya-Achola J, Kreiss JK . Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis. 2001, 28: 394-400
Richter L, Komárek A, Desmond C, Celentano D, Morin S, Sweat M, Chariyalertsak S, Chingono A, Gray G, Mbwambo J, Coates T . Reported physical and sexual abuse in childhood and adult HIV risk behaviour in three African countries: findings from Project Accept (HPTN-043). AIDS Behav. 2014, 18: 381-9
Risbud A, Chan-Tack K, Gadkari D, Gangakhedkar R, Shepherd ME, Bollinger RC, Mehendale S, Divekar A, Rompalo A, Quinn TC . The Etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexuallly transmitted disease clinics in Pune, India. Sex Transm Dis. 1999, 26: 55-62
Ritchwood TD, Hughes JP, Jennings L, MacPhail C, Williamson B, Selin A, Kahn K, Gomez-Olive FX, Pettifor A . Characteristics of Age-discordant Partnerships Associated with HIV Risk Among Young South African Women (HPTN 068). J Acquir Immune Defic Syndr.
Ritchwood, TD, Hughes, JP, Jennings L, MacPhail C, Williamson B, Selin A, Kahn K, Gómez-Olivé FX, Pettifor A . Factors associated with having significantly older male sexual partners among young rural South African women.
Rizzo-Price P, Stamper PD, Wood BJ, Reynolds SJ, Quinn TC, Gaydos C . Can nucleic acid amplification tests be used to test for chlamydia and gonorrhoea in microbicide trials?. Int J STD AIDS. 2007, 18: 543-45
Roesel DJ, Gwanzura L, Mason PR, Joffe M, Katzenstein DA . Polymerase chain reaction of Haemophilus ducreyi DNA. Sex Transm Infect. 1998, 74: 63-5
Roman Isler M, Golin C, Wang J, Hughes J, Justman J, Haley D, Kuo I, Adimora A, Chege W, Hodder S . Venues for Meeting Sex Partners and Partner HIV Risk Characteristics: HIV Prevention Trials Network (HPTN 064) Women’s HIV Seroincidence Study. AIDS and Behavior. 2016, 20: 1208-1218
Rompalo AM, Gaydos CA, Shah N, Tennant M, Crotchfelt KA, Madico G, Quinn TC, Daniel R, Shah KV, Gaydos JC, McKee KT Jr . Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis. 2001, 33: 1455-61
Rosen RK, Morrow KM, Carballo-Diéguez A, Mantell JE, Hoffman S, Gai F, Maslankowski L, El-Sadr WM, Mayer KH . Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study. J Womens Health (Larchmt). 2008, 17: 383-92 PMID:18328009
Rosenberg M, Pettifor A, Lippman SA, Thirumurthy H, Emch M, Miller WC, Selin A, Gomez-Olive FX, Hughes JP, Laeyendecker O, Tollman S, Kahn K . Relationship between community-level alcohol outlet accessibility and individual-level herpes simplex virus type 2 infection among young women in South Africa. Sexually Transmitted Diseases. 2015, 42: 259-65
Rosenberg M, Pettifor A, Van Rie A, Thirumurthy H, Emch M, Miller WC, Gomez-Olive FX, Twine R, Hughes JP, Laeyendecker O, Selin A, Kahn K . The Relationship between Alcohol Outlets, HIV Risk Behavior, and HSV-2 Infection among South African Young Women: A Cross-Sectional Study. PLoS One. 2015, 10: e0125510
Safren SA, Kumarasamy N, Hosseinipour M, Harwood MM, Hoffman I, McCauley M, Jumbe A, Nyirenda C, Mimiaga MJ, Solomon S, Celentano D, Mayer KH . Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India. AIDS Behav. 2006, 10: 443-50 PMID:16604297
Safren SA, Mayer KH, Ou S-S, McCauley M, Grinsztejn B, Hosseinipour MC, Kumarasamy N, Gamble T, Hoffman I, Celentano D, Chen YQ, Cohen MS . Adherence to Early Antiretroviral Therapy: Results from HPTN 052, A Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples. Journal of Acquired Immune Deficiency Syndromes. 2015, 69: 234-40
Sahasrabuddhe VV, Vermund SH . The Future of HIV Prevention: Control of Sexually Transmitted Infections and Circumcision Interventions. Infect Dis Clin North Am. 2007, 21: 241-57 PMCID: 2700301
Salazar-Gonzalez JF, Salazar MG, Learn GH, Fouda GG, Kang HH, Mahlokozera T, Wilks AB, Lovingood RV, Stacey A, Kalilani L, Meshnick SR, Borrow P, Montefiori DC, Denny TN, Letvin NL, Shaw GM, Hahn BH, Permar SR, et al . Origin and evolution of HIV-1 in breast milk determined by single genome amplification and sequencing. Journal of Virology. 2011, 85: 2751-63 PMCID: 3067940
Salomon EA, Mimiaga MJ, Husnik MJ, Welles SC, Manseau MW, Montenegro AB, Safren SA, BA Koblin, Chesney MA, Mayer KH . Depressive Symptoms, Utilization of Mental Health Care, Substance Use and Sexual Risk Among Young Men Who have Sex with Men in EXPLORE: Implications for Age-Specific Interventions. AIDS Behav. 2009, 13: 811-821 PMCID: 2718068
Sánchez J, Sal Y Rosas VG, Hughes JP, Baeten JM, Fuchs J, Buchbinder SP, Koblin BA, Casapia M, Ortiz A, Celum C . Male circumcision and risk of HIV acquisition among men who have sex with men. AIDS. 2010, 25: 519-23 PMCID: 3120051
Schachterle SE, Mtove G, Levens JP, Clemens EG, Shi L, Raj A, Munoz B, Reller ME, West S, Dumler JS, Sullivan D; PRET Project Team . Prevalence and density-related concordance of three diagnostic tests for malaria in a region of Tanzania with hypoendemic malaria. J Clin Microbiol. 2011, 49: 3885-91 PMCID: 3209109
Schackman BR, Eggman AA, Leff JA, Braunlin M, Felsen UR, Fitzpatrick L, Telzak EE, El-Sadr W, Branson BM . Costs of Expanded Rapid HIV Testing in Four Emergency Departments. Public Health Rep. 2016, 131 Suppl 1: 71-81
Schechter M, do Lago RF, de Melo MF, Sheppard HW, Guimaraes NC, Moreira RI, Faulhaber JC, Batista S, Harrison LH . Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. Projeto Praca Onze Study Group.. Acquir Immune Defic Syndr. 2000, 24: 175-7
Schreiber CA, Sammel M, Hillier SL, Barnhart KT . A Little Bit Pregnant: Modeling How the Accurate Detection of Pregnancy Can Improve HIV Prevention Trials. Am J Epidemiol. 2009, 169: 515-21 PMCID: 2732971
Schreiber CA, Whittington S, Cen L, Maslankowski L . Good intentions: risk factors for unintended pregnancies in the US cohort of a microbicide trial. Contraception. 2011, 83: 74-81 PMID:21134507
Seage GR 3rd, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP . Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol. 2001, 153: 619-27
Shaboltas AV, Toussova OV, Hoffman IF, Heimer R, Verevochkin SV, Ryder RW, Khoshnood K, Perdue T, Masse BR, Kozlov AP . HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. JAIDS. 2006, 41: 657-63 PMID: 16652041
Shafer RW, Chaung T, Hsu P, White CB, Katzenstein DA . Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. AIDS Res Hum Retroviruses. 1999, 15: 65-9
Sheppard HW, Celum CL, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buchbinder SP . HIV-1 infection in individuals with the CCR5-delta32/delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr. 2002, 29: 307-13
Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, Eshleman SH, Fleming T, Emel L, George K, Katzenstein DA, Wells J, Maponga CC, Mwatha A, Jones SA, Abdool Karim SS, Bassett MT . Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants From Birth to 6 Months. J Acquir Immune Defic Syndr. 2003, 34: 482-90
Shoptaw S, Montgomery B, Williams CT, El-Bassel N, Aramrattana A, Metsch L, Metzger DS, Kuo I, Bastos FI, Strathdee SA . Not just the needle: the state of HIV-prevention science among substance users and future directions. J Acquir Immune Defic Syndr. 2012, 63: S174-8 PMCID: 3739052
Silverthorn CF, Parsons TL . A validated new method for nevirapine quantitation in human plasma via high-performance liquid chromatography. Biomed Chromatogr. 2006, 20: 23-7 PMID: 15920701
Simwinga M, Bond V, Makola N, Hoddinott G, Belemu S, White R, Shanaube K, Seeley J, Moore A . Implementing Community Engagement for Combination Prevention: Lessons Learnt From the First Year of the HPTN 071 (PopART) Community-Randomized Study. Curr HIV/AIDS Rep. 2016
Sinkala M, Stout JP, Vermund SH, Goldenberg RL, Stringer JSA . Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV. Lancet. 2001, 358: 1611-12
Sista ND, Abdool Karim Q, Hinson K, Donnell D, Eshleman SH, Vermund SH . Experience in international clinical research: the HIV Prevention Trials Network. Clin Invest. 2011, 1: 1609-18 PMCID: 3281583
Sithole B, Mbhele L, Van Rooyen H, Khumalo-Sakutukwa G, Richter L . Only skin deep: limitations of public health understanding of male circumcision in South Africa. S Afr Med J. 2009, 99: 647 PMCID: 2861782
Smita J, Soma D, Beverly B, Albert P, JoAnn K, Fang G, Missy C, Lydia ST, Anjali P, Arun R, Sanjay M, Steven J R; HIV Prevention Trial Network HPTN 047 Protocol Team . Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India. AIDS Res Ther (Epub). 2006, 3: 4 PMCID: 1435917
Smith MK, Rutstein SE, Powers KA, Fidler S, Miller WC, Eron JJ Jr, Cohen MS . The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr. 2013, 63: S187-99 PMCID: 4015137
Solomon S, Buck J, Chaguturu SK, Ganesh AK, Kumarasamy N . Stopping HIV before it begins: issues faced by women in India. Nat Immunol. 2003, 4: 719-21
Solomon SS, Solomon S, Masse BR, Srikrishnan AK, Beauchamp G, Thamburaj E, Gulvady M, Anand S, Mayer KH . Risk reduction counseling is associated with decreased HIV transmission-associated behaviors in high-risk Indian heterosexuals. J Acquir Immune Defic Syndr. 2006, 42: 478-83 PMID: 16763526
Spielberg F, Critchlow C, Vittinghoff E, Coletti AS, Sheppard H, Mayer KH, Metzgerg D, Judson FN, Buchbinder S, Chesney M, Gross M . Home collection for frequent HIV testing: acceptability of oral fluids, dried blood spots and telephone results. HIV Early Detection Study Group. AIDS. 2000, 14: 1819-28
Spielberg F, Critchlow C, Vittinghoff E, Gross M, Doherty-Iddings P, Scotti R, Judson FN, Marmor M, Buchbinder S . Slow diffusion of home HIV-specimen collection: provider concerns at odds with client preferences. Sex Transm Dis. 2001, 28: 51-7
Srikrishnan AK, Hendriksen E, Vallabhaneni S, Johnson SL, Raminani S, Kumarasamy N, Hobsen J, Solomon S, Mayer KH, Safren SA . Sexual behaviors of individuals with HIV living in South India: a qualitative study. AIDS Educ Prev. 2007, 19: 334-45
Srikrishnan AK, Venkatesh K, Solomon S, Thamburaj E, Anand S, Kosalaraman KG, Balakrishnan P, Mayer K . Expansion of HIV Laboratory Diagnostic Services in Chennai, India 2001-2006: Is the Growth Commensurate with the Need?. PLoS One. 2008, 3: e3471 PMCID:2565796
Stephenson J . Health agencies update: HIV Prevention Trials Network. JAMA. 2000, 284: 822
Stone E, Heagerty P, Vittinghoff E, Douglas JM, Koblin BA, Mayer KH, Celum CL, Gross M, Woody GE, Marmor M, Seage GR, Buchbinder SP, Douglas JM Jr, Seage GR 3rd . Correlates of condom failure in a sexually active cohort of men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol. 1999, 20: 495-501
Straseski JA, Stolbach A, Clarke W . Opiate-positive immunoassay screen in a pediatric patient. Clin Chem. 2010, 56: 1220-3 PMCID: 2975969
Stringer E, Read JS, Hoffman I, Valentine M, Aboud S, Goldenberg RL . Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. S Afr Med J. 2010, 100: 58-64 PMCID: 3090676
Stringer EM, Sinkala M, Kumwenda R, Chapman V, Mwale A, Vermund SH, Goldenberg RL, Stringer JS . Personal risk perception, HIV knowledge and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric population. J Acquir Immune Defic Syndr. 2004, 35: 60-6
Stringer JS, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA . Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2000, 24: 369-77
Stringer JS, Sinkala M, Chapman V, Acosta EP, Aldrovandi GM, Mudenda V, Stout JP, Goldenberg RL, Kumwenda R, Vermund SH . Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS. 2003, 17: 1659-65
Stringer JS, Sinkala M, Goldenberg R, Vermund S, Acosta E . Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Lancet. 2003, 362: 667
Stringer JS, Sinkala M, Goldenberg RL, Kumwenda R, Acosta EP, Aldrovandi GM, Stout JP, Vermund SH . Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. AIDS. 2004, 18: 939-43
Stringer JS, Sinkala M, Rouse DJ, Goldenberg RL, Vermund SH . Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health. 2002, 92: 365-6
Sucato G, Celum CL, Dithmer D, Ashley RL, Wald A . Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescehts. Pediat Infect Dis. 2001, 20: 422-6
Sugarman J, Corneli A, Donnell D, Liu TY, Rose S, Celentano D, Jackson B, Aramrattana A, Wei L, Shao Y, Liping F, Baoling R, Dye B, Metzger D . Are there adverse consequences of quizzing during informed consent for HIV research?. J Med Ethics. 2011, 37: 693-7 PMCID: 3200567
Sugarman J, Grace WC . Ethics and the standards of prevention in HIV prevention trials - comment. AIDS. 2010, 24: 2298-9 PMID:20736687
Sugarman J, Mayer KH . Ethics and pre-exposure prophylaxis for HIV infection. J Acquir Immune Defic Syndr. 2013, 63: S135-9 PMCID: 3728665
Sugarman J, Rose SM, Metzger D . Ethical issues in HIV prevention research with people who inject drugs. Clin Trials. 2014, 11: 239-45
Sugarman J, Stalter R, Bokoch K, Liu T, and Donnell D, Donnell D . Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs. IRB: Ethics & Human Research. 2015, 37: 17-19
Sweat M, Morin S, Celentano D, Mulawa M, Singh B, Mbwambo J, Kawichai S, Chingono A, Khumalo-Sakutukwa G, Gray G, Richter L, Kulich M, Sadowski A, Coates T . Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infectious Disease. 2011, 11: 525-32 PMCID: 3156626
Tabet S, Sanchez J, Lama J, Goicochea P, Campos P, Rouillon M, Cairo JL, Ueda L, Watts D, Celum C, Holmes K . HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS. 2002, 16: 1271-1277
Tabet SR, Callahan MM, Mauck CK, Gai F, Coletti AS, Profy AT, Moench TR, Soto-Torres LE, Poindexter AN, Frezieres RG, Walsh TL, Kelly CW, Richardson BA, van Damme L, Celum CL . Safety and Acceptability of Penile Application of 2 Candidate Topical Microbicides: BufferGel and PRO 2000 Gel: 3 Randomized Trials in Healthy Low-Risk Men and HIV-Positive Men. J Acquir Immune Defic Syndr. 2003, 33: 476-83
Tabet SR, Surawicz C, Horton S, Paradise M, Coletti AS, Gross M, Fleming TR, Buchbinder S, Haggitt RC, Levine H, Kelly CW, Celum CL . Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis. 1999, 26: 564-71
Taha TE, Brown ER, Hoffman IF, Fawzi W, Read JS, Sinkala M, Martinson FE, Kafulafula G, Msamanga G, Emel L, Adeniyi-Jones S, Goldenberg R . A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS. 2006, 20: 1313-21 PMID: 16816561
Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, Kumwenda NI, Miotti PG . Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS. 1998, 12: 197-203
Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, Markakis D, van Der Hoeven L, Liomba GN, Chiphangwi JD, Miotti PG . Morbidity among human immunodeficiency virus-1-infected and -uninfected African children. Pediatrics. 2000, 106: E77
Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG . Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998, 12: 1699-706
Taha TE, Hoover DR, Kumwenda NI, Fiscus SA, Kafulafula G, Nkhoma C, Chen S, Piwowar E, Broadhead RL, Jackson JB, Miotti PG . Late postnatal transmission of HIV-1 and associated factors. J Infect Dis. 2007, 196: 10-14 PMID: 17538877
Taha TE, James MM, Hoover DR, Sun J, Laeyendecker O, Mullis CE, Kumwenda JJ, Lingappa JR, Auvert B, Morrison CS, Mofensen LM, Taylor A, Fowler MG, Kumenda NI, Eshleman SH . Association of recent HIV infection and in-utero HIV-1 transmission. AIDS. 2011, 25: 1357-1364 PMCID: 3263827
Taha TE, Kumwenda N, Gibbons A, Hoover D, Lema V, Fiscus S, Mukiibi J, Liomba G, Broadhead R . Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants. AIDS. 2002, 16: 851-8
Taha TE, Kumwenda NI, Hoover DR, Biggar RJ, Broadhead RL, Cassol S, van der Hoven L, Markakis D, Liomba GN, Chiphangwi JD, Miotti PG . Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age. AIDS. 2000, 14: 453-9
Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, Broadhead RL . Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting; a randomized controlled trial. JAMA. 2004, 292: 202-9
Taha TE, Kumwenda, Broadhead, Hoover, Graham, Hoeven, LV, D, Markakis, Liomba, GN, Chiphangwi, JD, Miotti, PG, Kumwenda NI, Broadhead RL, Hoover DR, Graham SM, Van Der Hoeven . Mortality after the first year of life among HIV infected and uninfected children. Ped Infect Dis J. 1999, 18: 689-94
Tedrow VA, Zelaya CE, Kennedy CE, Morin SF, Khumalo-Sakutukwa G, Sweat MD, Celentano DD . No "Magic Bullet": Exploring community mobilization strategies used in a multi-site community based randomized controlled trial: Project Accept (HPTN 043). AIDS Behav. 2012, 16: 1217-26 PMCID: 3400971
Thompson CG, Cohen MS, Kashuba AD . Antiretroviral pharmacology in mucosal tissues. J Acquir Immune Defic Syndr. 2013, 63: S240-7 PMCID:3951793
Tien PC, Chiu T, Latif AS, Ray S, Batra M, Contag CH, Zejenah L, Mbizvo M, Delwart EL, Mullins JI, Katzenstein DA . Primary subtype C HIV-1 infection in Harare, Zimbabwe. J Acquir Immune Defic Syndr Hum Retrovirol. 1999, 20: 147-53
Tieu HV, Liu TY, Hussen S, Connor M, Wang L, Buchbinder S, Wilton L, Gorbach P, Mayer K, Griffith S, Kelly C, Elharrar V, Phillips G, Cummings V, Koblin B, Latkin C; HPTN 061 . Sexual Networks and HIV Risk among Black Men Who Have Sex with Men in 6 U.S. Cities. PLoS One. 2015, 10: e0134085
Tieu HV, Rolland M, Hammer SM, Sobieszczyk ME . Translational research insights from completed HIV vaccine efficacy trials. J Acquir Immune Defic Syndr. 2013, 63: S150-4
Tobian AA, Gaydos C, Gray RH, Kigozi G, Serwadda D, Quinn N, Grabowski MK, Musoke R, Ndyanabo A, Nalugoda F, Wawer MJ, Quinn TC . Male circumcision and Mycoplasma genitalium infection in female partners: a randomised trial in Rakai, Uganda. Sex Transm Infect. 2014, 90: 150-4
Towler WI, Barlow-Mosha L, Church JD, Bagenda D, Ajuna P, Mubiru M, Musoke P, Eshleman SH . Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Res Hum Retroviruses. 2010, 26: 563-8 PMCID: 2875950
Towler WI, Church JD, Eshleman JR, Fowler MG, Guay LA, Jackson JB, Eshleman SH . Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq). AIDS Res Hum Retroviruses. 2008, 24: 1209-13. PMCID:2562759
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson JB, Eshleman SH . Analysis of HIV diversity using a high-resolution melting assay. AIDS Res Hum Retroviruses. 2010, 26: 913-8 PMCID: 2920076
Valsamakis A . Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007, 20: 426-39
van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K . Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr. 2001, 26: 21-7
Van Der Pol B, Williams JA, Taylor SN, Cammarata CL, Rivers CA, Body BA, Nye M, Fuller D, Schwebke JR, Barnes M, Gaydos CA . Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system. J Clin Microbiol. 2014, 52: 885-9
van Rooyen H, McGrath N, Chirowodza A, Joseph P, Fiamma A, Gray G, Richter L, Coates T . Mobile VCT: Reaching Men and Young People in Urban and Rural South African Pilot Studies (NIMH Project Accept, HPTN 043). AIDS Behav. 2013, 17: 2946-53 PMCID: 3597746
Venkatesh KK, Madiba P, De Bruyn G, Lurie MN, Coates TJ, Gray GE . Who gets tested for HIV in a South African urban township? Implications for test and treat and gender-based prevention interventions. JAIDS. 2011, 56: 151-65 PMCID: 3137901
Vermund SH, Fidler SJ, Ayles H, Beyers N, Hayes RJ. . Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia. J Acquir Immune Defic Syndr. 2013, 63: S221-7 PMCID: 3739051
Vermund SH, Hodder SL, Justman JE, Koblin BA, Mastro TD, Mayer KH, Wheeler DP, El-Sadr WM . Addressing research priorities for prevention of HIV infection in the United States. Clin Infect Dis. 2010, 50: S149-55 PMCID: 2862583
Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, Martinez-Maza O, Bream JH . The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015, 29: 463-71
Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR 3rd, Cohen MS, Freedberg KA. . Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. NEJM. 2013, 369: 1715-25 PMCID: 3913536
Watson-Jones D, Wald A, Celum C, Lingappa J, Weiss HA, Changalucha J, Baisley K, Tanton C, Hayes RJ, Marshak JO, Gladden RG, Koelle DM . Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol. 2010, 48: 3496-503 PMCID: 2953087
Watts DH, Brown ER, Maldonado Y, Herron C, Chipato T, Reddy L, Moodley D, Nakabiito C, Manji K, Fawzi W, George K, Richardson P, Zwerski S, Coovadia H, Fowler M; HPTN 046 Protocol Team . HIV Disease Progression in the First Year After Delivery Among African Women Followed in the HPTN 046 Clinical Trial. J Acquir Immune Defic Syndr. 2013, 64: 299-306 PMCID: 3800257
Wei L, Chen J, Rodolph M, Beauchamp G, M 0226 Sse B, Li R, Wang S, Ruan Y, Lai S, Zhang L, Zhou F, Rose SM, Perdue T, Shao Y, Jackson JB . HIV Incidence, Retention, and Changes of High-Risk Behaviors Among Rural Injection Drug Users in Guangxi, China. Subst Abus. 2006, 274: 53-61 PMID: 17347126
Welte A, McWalter TA, Laeyendecker O, Hallet TB . Using tests for recent infection to estimate incidence: Problems and Prospects for HIV. Euro Surveill. 2010, 15: pii: 19589 PMCID: 2937566
Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Brookmeyer R, Quinn TC, Laeyendecker O . Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection. PLoS One. 2013, 8: e55525 PMCID: 3577851
Westheimer EF, Urassa W, Msamanga G, Baylin A, Wei R, Aboud S, Kaaya S, Fawzi WW . Acceptance of HIV Testing Among Pregnant Women in Dar-es-Salaam, Tanzania. J Acquir Immune Defic Syndr. 2004, 37: 1197-1205
Williams C, Eisenberg M, Becher J, Davis-Vogel A, Fiore D, Metzger D . Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks. J Acquir Immune Defic Syndr. 2013, 63: S90-4 PMCID: In Process
Williams JK, Wilton L, Magnus M, Wang L, Wang J, Dyer TP, Koblin BA, Hucks-Ortiz C, Fields SD, Shoptaw S, Stephenson R, O'Cleirigh C, Cummings V; HIV Prevention Trials Network 061 Study Team . Relation of Childhood Sexual Abuse, Intimate Partner Violence, and Depression to Risk Factors for HIV Among Black Men Who Have Sex With Men in 6 US Cities. Am J Public Health. 2015, 105: 2473-81
Wilson CM, Gray G, Read JS, Mwatha A, Lala S, Johnson S, Violari A, Sibiya PM, Fleming TR, Koonce A, Vermund SH, McIntyre J . Tolerance and Safety of Different Concentrations of Chlorhexidine for Peripartum Vaginal and Infant Washes: HIVNET 025. J Acquir Immune Defic Syndr. 2004, 35: 138-43
Wilson SE, Pedersen SL, Kunich JC, Wilkins VL, Mann DL, Mazzara GP, Tartaglia J, Celum CL, Sheppard HW . Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res Hum Retroviruses. 1998, 14: 925-37
Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, Siliciano JD, Quinn TC, Siliciano RF . Identification of Nevirapine-Resistant HIV-1 in the Latent Reservoir after Single-Dose Nevirapine to Prevent Mother-to-Child Transmission of HIV-1. J Infect Dis. 2009, 199: 1301-9 PMCID:2703715
Wong LH, Van Rooyen H, Modiba P, Richter L, Gray G, McIntyre JA, Schetter CD, Coates T . Test and Tell: Correlates and Consequences of Testing and Disclosure of HIV Status in South Africa (HPTN 043 Project Accept). JAIDS. 2009, 50: 215-22 PMCID:2729272
Woodsong C . Covert use of topical microbicides: implications for acceptability and use. Perspect Sex Reprod Health. 2004, 36: 127-31
Woodsong C, Alleman P, Musara P, Chandipwisa A, Chirenje M, Martinson F, Hoffman I . Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe. AIDS Behav. 2012, 16: 785-90 PMCID: 3658446
Woody G, VanEttne-Lee ML, McKirnan D, Donnell D, Seage G, Gross M . Substance Use Among Men who have Sex with Men: Comparison with a National Household Survey. J Acquir Immune Defic Syndr. 2001, 27: 86-90
Woody GE, Donnell D, Seage GR, Metzger D, Marmor M, Koblin BA, Buchbinder S, Gross M, Stone B, Judson FN . Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug Alcohol Depend. 1999, 53: 197-205
Young SD, Hlavka Z, Modiba P, Gray G, Rooyen HV, Richter L, Szekeres G, Coates T . HIV-Related stigma, social norms, and HIV testing in Soweto and Vulindlela, South Africa: National Institutes of Mental Health Project Accept (HPTN 043). J Acquir Immune Defic Syndr. 2010, 55: 620-4 PMCID: 3136617
Zhang Y, Shan H, Trizzino J, Ruan Y, Beauchamp G, Mâsse B, Ma J, Gu Y, He Y, Rui B, Wang J, Poundstone K, Jiang Y, Brooks Jackson J, Shao Y . Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China. J Infect. 2007, 54: 285-90 PMID: 16831464
Zhang Y, Shan H, Trizzino J, Ruan Y, Beauchamp G, Mâsse B, Ma J, Rui B, Wang J, Liu M, Wang Y, He Y, Poundstone K, Jiang Y, Jackson JB, Shao Y . HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China. Int J Infect Dis. 2007, 11: 318-23 PMID: 17321184
Zulu I, Schuman P, Musonda R, Chomba E, Mwinga K, Sinkala M, Chisembele M, Mwaba P, Kasonde D, Vermund SH . Priorities for Antiretroviral Therapy Research in Sub-Saharan Africa: A 2002 Consensus Conference in Zambia. J Acquir Immune Defic Syndr. 2004, 36: 831-34 PMCID: 2745050